Market Newsdesk

MONTREAL, Feb. 01, 2021 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG) (Dynacor or the Corporation) announced today the Corporation is changing its dividend payment frequency schedule to monthly from quarterly beginning in February 2021. The declaration of a dividend payment of CA $0.005 per common share, which will be payable on February 17, 2021, to shareholders of record as of the close of business on February 8, 2021. This dividend represents the eleventh dividend and first monthly payment made to shareholders.

President and CEO Jean Martineau states, “I am pleased to announce the change in our dividend policy to monthly from quarterly payments. This compound friendly and value-added shareholder move is based on Dynacor’s healthy balance sheet, stable free cash flow model and expectation that 2021 and beyond will be among the company’s very best. We believe the new monthly income streams distributed from Dynacor will be an attractive part of our dividend policy from which a large percentage of our shareholder base will benefit.”

The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes.

The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board.

ABOUT DYNACOR

Dynacor is a dividend-paying ASM (artisanal and small-scale mining) gold ore industrial corporation headquartered in Montreal, Canada. The corporation is engaged in metal sales through the processing of ore purchased from the ASM industry. At present, Dynacor has ASM ore purchasing and processing operations in Peru. The corporation’s management and processing team have decades of experience and expertise as it sold its first ASM gold bar in 1998.

Dynacor produces environmental and socially responsible gold through its PX IMPACT® gold program. A growing number of supportive firms from the fine luxury jewelry, watchmakers and investment sectors pay a small premium to our customer and strategic partner for this PX IMPACT® gold.

The premium provides direct investment to develop health and education projects for our artisanal and small-scale miner’s communities.

Dynacor is listed on the Toronto Stock Exchange (DNG).

FORWARD-LOOKING INFORMATION

Certain statements in the preceding may constitute forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Dynacor, or industry results, to be materially different from any future result, performance or achievement expressed or implied by such forward-looking statements. These statements reflect management’s current expectations regarding future events and operating performance as of the date of this news release.

Dynacor (TSX: DNG)

Website: http://www.dynacor.com
Twitter: http://twitter.com/DynacorGold

PDF available: http://ml.globenewswire.com/Resource/Download/dc41ecff-38ae-48c7-8d61-53553bdf3d60

CONTACT: For more information, please contact:

Director, Shareholder Relations
Dale Nejmeldeen
Dynacor Gold Mines Inc.
T: 514-393-9000 #230
E: [email protected]

GETTYSBURG, Pa., Feb. 01, 2021 (GLOBE NEWSWIRE) — The Board of Directors of ACNB Corporation recently approved and declared the payment of the regular quarterly cash dividend. The cash dividend of $0.25 per share is payable on March 15, 2021, to shareholders of record on March 1, 2021. This per share amount will result in aggregate dividend payments of approximately $2.2 million to ACNB Corporation shareholders in the first quarter of 2021. In comparison to a year ago, ACNB Corporation also paid a $0.25 dividend per share in the first quarter of 2020.

“At ACNB Corporation, there is a long history of continuous and meaningful quarterly dividends paid to shareholders. For the first quarter of 2021, the Board of Directors voted to sustain this history even though we still face challenges while operating in a COVID-19 environment,” said James P. Helt, ACNB Corporation President & Chief Executive Officer. “The quarterly dividend to our shareholders remains steady at $0.25 per share, as it has throughout the pandemic.”

Mr. Helt continued, “Looking forward, there is still uncertainty ahead. However, at ACNB Corporation’s community banking and insurance agency subsidiaries, we have proven to be resilient and will continue to adapt in 2021 to further our commitment to our customers, shareholders and communities.”
        
ACNB Corporation, headquartered in Gettysburg, PA, is the $2.6 billion financial holding company for the wholly-owned subsidiaries of ACNB Bank, Gettysburg, PA, and Russell Insurance Group, Inc., Westminster, MD. Originally founded in 1857, ACNB Bank serves its marketplace with banking and wealth management services, including trust and retail brokerage, via a network of 21 community banking offices, located in the four southcentral Pennsylvania counties of Adams, Cumberland, Franklin and York, as well as loan offices in Lancaster and York, PA, and Hunt Valley, MD. As divisions of ACNB Bank operating in Maryland, FCB Bank and NWSB Bank serve the local marketplace with a network of five and seven community banking offices located in Frederick County and Carroll County, MD, respectively. Russell Insurance Group, Inc., the Corporation’s insurance subsidiary, is a full-service agency with licenses in 44 states. The agency offers a broad range of property, casualty, health, life and disability insurance serving personal and commercial clients through office locations in Westminster, Germantown and Jarrettsville, MD, and Gettysburg, PA. For more information regarding ACNB Corporation and its subsidiaries, please visit acnb.com.

FORWARD-LOOKING STATEMENTS – In addition to historical information, this press release may contain forward-looking statements. Examples of forward-looking statements include, but are not limited to, (a) projections or statements regarding future earnings, expenses, net interest income, other income, earnings or loss per share, asset mix and quality, growth prospects, capital structure, and other financial terms, (b) statements of plans and objectives of management or the Board of Directors, and (c) statements of assumptions, such as economic conditions in the Corporation’s market areas. Such forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expects”, “may”, “intends”, “will”, “should”, “anticipates”, or the negative of any of the foregoing or other variations thereon or comparable terminology, or by discussion of strategy. Forward-looking statements are subject to certain risks and uncertainties such as local economic conditions, competitive factors, and regulatory limitations. Actual results may differ materially from those projected in the forward-looking statements. Such risks, uncertainties and other factors that could cause actual results and experience to differ from those projected include, but are not limited to, the following: the effects of governmental and fiscal policies, as well as legislative and regulatory changes; the effects of new laws and regulations, specifically the impact of the Coronavirus Response and Relief Supplemental Appropriations Act, the Coronavirus Aid, Relief, and Economic Security Act, the Tax Cuts and Jobs Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act; impacts of the capital and liquidity requirements of the Basel III standards; the effects of changes in accounting policies and practices, as may be adopted by the regulatory agencies, as well as the Financial Accounting Standards Board and other accounting standard setters; ineffectiveness of the business strategy due to changes in current or future market conditions; future actions or inactions of the United States government, including the effects of short- and long-term federal budget and tax negotiations and a failure to increase the government debt limit or a prolonged shutdown of the federal government; the effects of economic conditions particularly with regard to the negative impact of severe, wide-ranging and continuing disruptions caused by the spread of Coronavirus Disease 2019 (COVID-19) and the responses thereto on the operations of the Corporation and current customers, specifically the effect of the economy on loan customers’ ability to repay loans; the effects of competition, and of changes in laws and regulations on competition, including industry consolidation and development of competing financial products and services; the risks of changes in interest rates on the level and composition of deposits, loan demand, and the values of loan collateral, securities, and interest rate protection agreements, as well as interest rate risks; difficulties in acquisitions and integrating and operating acquired business operations, including information technology difficulties; challenges in establishing and maintaining operations in new markets; the effects of technology changes; volatilities in the securities markets; the effect of general economic conditions and more specifically in the Corporation’s market areas; the failure of assumptions underlying the establishment of reserves for loan losses and estimations of values of collateral and various financial assets and liabilities; acts of war or terrorism; disruption of credit and equity markets; the ability to manage current levels of impaired assets; the loss of certain key officers; the ability to maintain the value and image of the Corporation’s brand and protect the Corporation’s intellectual property rights; continued relationships with major customers; and, potential impacts to the Corporation from continually evolving cybersecurity and other technological risks and attacks, including additional costs, reputational damage, regulatory penalties, and financial losses. We caution readers not to place undue reliance on these forward-looking statements. They only reflect management’s analysis as of this date. The Corporation does not revise or update these forward-looking statements to reflect events or changed circumstances. Please carefully review the risk factors described in other documents the Corporation files from time to time with the SEC, including the Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Please also carefully review any Current Reports on Form 8-K filed by the Corporation with the SEC.

Contact: Lynda L. Glass
EVP/Secretary &
Chief Governance Officer
717.339.5085
[email protected]

New York, Feb. 01, 2021 (GLOBE NEWSWIRE) — Grayscale Investments®, the world’s largest digital currency asset manager and sponsor of Grayscale® Ethereum Trust (OTCQX: ETHE) (the “Trust”), today announced that the Trust will resume the private placement of its Shares. The Trust’s private placement is offered on a periodic basis throughout the year and is now available to accredited investors for daily subscription.* The Trust is an SEC reporting company with its Shares registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The Trust is solely and passively invested in Ethereum and was created for investors seeking exposure to Ethereum through a singular investment vehicle without the challenges of buying, storing, and safekeeping Ethereum directly. As of January 29, 2021, the Trust had more than $4 billion in assets under management (AUM) and each share of the Trust represents 0.01027553 Ethereum.

The Trust’s investment objective is for the value of its Shares (based on Ethereum per Share) to reflect the value of Ethereum held by the Trust, less the Trust’s expenses and other liabilities. To date, the Trust has not met its investment objective and the Shares quoted on OTCQX have not reflected the value of Ethereum held by the Trust less the Trust’s expenses and other liabilities, but have instead traded at a substantial premium over such value.  

Following a six-month holding period, shareholders who invest in the private placement may elect to sell their Shares at prices dictated by the market under the symbol: ETHE. 

The Trust is an investment vehicle with Shares titled in the investor’s name, providing a familiar structure for financial and tax advisors and easy transferability to beneficiaries under estate laws. Additionally, Shares are eligible to be held in certain IRA, Roth IRA, and other brokerage and investor accounts.

The private placement Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities laws, and the Shares are being offered pursuant to an exemption from registration provided by Rule 506(c) of Regulation D under the Securities Act and in reliance on similar exemptions under applicable state laws. An investment in the Shares of the Trust is suitable only for sophisticated, well-informed investors, and investors will be required to represent that they are accredited investors as such term is defined in Rule 501(a) of Regulation D under the Securities Act.

As a result, the Shares are restricted shares and are subject to a six-month holding period in accordance with Rule 144 under the Securities Act. Because of the six-month holding period and the lack of an ongoing redemption program, Shares should not be purchased by any investor who is not willing and able to bear the risk of investment and lack of liquidity for at least six months. No assurances are given that after the six-month holding period, there will be any market for the resale of Shares, or, if there is such a market, as to the price at which such Shares may be sold into such a market. Qualified investors should refer to the Trust’s private placement memorandum, which is available from Grayscale at [email protected], for a discussion of these and other risks.

For more information, please visit: https://grayscale.co/ethereum-trust/. 

*The Trust offers a private placement to accredited investors. The Trust does not currently operate a redemption program.

This press release is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal, nor shall there be any sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

About Grayscale Investments
®
 

Grayscale Investments is the world’s largest digital currency asset manager, with more than $27.7B in assets under management as of January 29, 2021. Through its family of investment products, Grayscale provides access and exposure to the digital currency asset class in the form of a traditional security without the challenges of buying, storing, and safekeeping digital currencies directly. With a proven track record and unrivaled experience, Grayscale’s products operate within existing regulatory frameworks, creating secure and compliant exposure for investors. For more information, please visit www.grayscale.co and follow @Grayscale.

Washington, Feb. 01, 2021 (GLOBE NEWSWIRE) — Hunton Andrews Kurth LLP is pleased to announce that former D.C. Circuit Judge Thomas B. Griffith has joined the firm as a special counsel in its issues and appeals practice. Judge Griffith will be based in Washington, D.C., where he will focus his practice on appellate litigation, Congressional and internal investigations, and strategic counseling.

Appointed to the United States Court of Appeals for the D.C. Circuit by President George W. Bush in 2005, Judge Griffith served on the court for 15 years until his retirement in 2020. During his judicial tenure, Judge Griffith authored more than 200 opinions touching a wide range of issues, including administrative law, environmental law, energy law and congressional investigations.

“Judge Griffith served the D.C. Circuit with distinction, and is among the most widely-respected former appellate judges in the country,” said Hunton Andrews Kurth Managing Partner Wally Martinez. “We are honored to have him join the firm.”

As a member of the D.C. Circuit, Judge Griffith was appointed by the Chief Justice of the United States to serve on the Judicial Conference’s Committee on the Judicial Branch, which concerns the judiciary’s relationship to the Executive Branch and Congress, and the Code of Conduct Committee, which sets the ethical standards that govern the federal judiciary.

Before his appointment to the D.C. Circuit, Judge Griffith served as Senate Legal Counsel from 1995 to 1999. In that role, he represented the interests of the U.S. Senate in litigation and provided non-partisan legal advice to Senate leadership. He represented the institutional interests of the Senate in litigation over the Line Item Veto Act and in numerous committee investigations.

“Judge Griffith’s acumen, judicial temperament and dedication to the rule of law defined his career as a jurist and helped guide the D.C. Circuit through some of its most challenging and high-profile cases,” said Elbert Lin, co-chair of Hunton Andrews Kurth’s issues and appeals practice. “His invaluable experience, insight and reputation bring additional strength to our practice.”

“Throughout his impressive judicial career, Judge Griffith led by example in practicing civic charity and professionalism,” said practice co-chair Stuart Raphael. “We are privileged to have him as the newest addition to our issues and appeals practice.”

Earlier in his legal career, Judge Griffith spent several years in private practice and served as general counsel for Brigham Young University, where he received his undergraduate degree. A graduate of the University of Virginia School of Law, Judge Griffith is a Lecturer on Law at Harvard Law School and has taught previously at the law schools at Stanford and BYU.

Judge Griffith is a senior advisor at the National Institute for Civil Discourse and a member of the advisory board of the Neal A. Maxwell Institute for Religious Scholarship at BYU. He has long been active in international rule of law projects and is currently a member of the International Advisory Board of the CEELI Institute in Prague, which promotes international legal reform projects in Eastern Europe and Eurasia.

Attorneys in Hunton Andrews Kurth’s issues and appeals group represent clients in federal and state appellate courts nationwide, including in the Supreme Court of the United States. Among the firm’s lawyers are former justices of the Texas Supreme Court and the Supreme Court of Virginia, two former state solicitors general, and more than 30 who have clerked for federal and state appellate judges throughout the country.

About Hunton Andrews Kurth LLP

With 1,000 lawyers in the United States, Asia, Europe and the Middle East, Hunton Andrews Kurth LLP serves clients across a broad range of complex transactional, litigation and regulatory matters. We are known for our strength in the energy, financial services, real estate, and retail and consumer products industries, as well as our considerable experience in more than 100 distinct areas of practice, including privacy and cybersecurity, intellectual property, environmental, and mergers and acquisitions. Our full-service litigation practice is one of the largest in the country, with particular depth in key litigation markets such as Texas, California, Florida and the Mid-Atlantic.

Attachment

• Judge Griffith

Jeremy Heallen
Hunton Andrews Kurth LLP
(713) 220-3713
[email protected]

• BSH Home Appliances Corporation in exclusive group of companies that meet the Top Employers Institute’s strict criteria for exceptional employee offerings
• BSH has received this annual certification since 2016, consistently upholding an environment of growth and success for its team members nationwide

IRVINE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) — BSH Home Appliances Corporation has been recognized by the Top Employers Institute as a Top Employer 2021 in the United States of America. BSH has received this award for the sixth consecutive year, highlighting the company’s commitment to creating a collaborative environment that inspires and supports employees while nurturing and developing talent through all levels of its organization.

The Top Employers Institute program certifies organizations based on the participation and results of their HR Best Practices Survey. This survey covers six HR domains consisting of 20 topics such as People Strategy, Work Environment, Talent Acquisition, Learning, Well-being and Diversity & Inclusion and more.

“BSH Home Appliances is honored to be among an exclusive group of companies that met the Top Employers Institute’s strict criteria for outstanding human resource policies and practices,” said Marlies van der Horst, Head of Human Resources, BSH Home Appliances Corporation, Region North America. “Earning Top Employers United States of America certification for the sixth consecutive year is a testament to our company’s consistent commitment to maintaining an environment of employee engagement and a better world of work.”

Top Employers Institute CEO David Plink says: “Despite the challenging year we have experienced (which has certainly made an impact on organizations around the globe), BSH Home Appliances has continued to demonstrate the power of putting their people first in the workplace. We are proud to share this year’s announcement and congratulate the organizations who have been certified in their respective countries through the Top Employers Institute program.”

To learn more about the Top Employers Institute and the Top Employers Certification, visit: www.top-employers.com. To learn more about BSH Home Appliances, please visit: https://www.bsh-group.com/us/.

About BSH Home Appliances Corporation
BSH Home Appliances Corporation produces and markets small and major home appliances that are known across North America for their high-quality and superior innovation. BSH sells its Gaggenau, Thermador and Bosch branded products throughout North America, through distributors, independent appliance dealers, national and regional retailers, builders and large buying groups. BSH Home Appliances Corporation is a wholly owned subsidiary of BSH Home Appliances Group, headquartered in Munich, Germany, the largest manufacturer of home appliances in Europe and one of the leading companies in the sector worldwide. Manufacturing facilities are located in New Bern, North Carolina, and LaFollette, Tennessee. BSH Technology and Development Centers are located in Oak Ridge and Caryville, Tennessee and New Bern, North Carolina. https://www.bsh-group.com/us/

About Top Employers Institute

Top Employers Institute is the global authority on recognizing excellence in People Practices. We help accelerate these practices to enrich the world of work. Through the Top Employers Institute Certification Program, participating companies can be validated, certified and recognized as an employer of choice. Established 30 years ago, Top Employers Institute has certified over 1 600 organizations in 120 countries/regions. These certified Top Employers positively impact the lives of over 7 million employees globally.

Top Employers Institute. For a better world of work.
www.top-employers.com

Contact:

Debbie Ehrman
Finn Partners
310-882-4016
[email protected]

SEATTLE, Feb. 01, 2021 (GLOBE NEWSWIRE) — 2nd Watch has appointed Chris Whaley to Executive Vice President, Cloud Solutions Sales. Chris brings over 20 years focused on the Banking & Capital Markets, Healthcare, and Insurance industries. Chris most recently was a partner at IBM leading Cloud Application services. Prior to that, Chris served as Senior Vice President of business development at Cloudticity, a cloud managed services, compliance and security company focused on migrating healthcare and life science companies to AWS and Azure.

“As more companies embrace digital transformation, enterprises are seeking well-regarded, trusted stewards to advise, modernize and orchestrate the migration of their applications and data to the cloud,” says Doug Schneider, CEO at 2nd Watch. “Chris brings a wealth of experience in the cloud arena and enables 2nd Watch to further accelerate the rapid growth we’ve encountered enabling enterprises’ cloud native development and capabilities.”  

As EVP, Cloud Solutions Sales, Chris will lead the 2nd Watch field solution teams globally, addressing the business problems 2nd Watch clients are commonly trying to solve. Seeing increased focus from its clients on application modernization and data and analytics to enable business growth, Chris will contribute to 2nd Watch’s emphasis on growing those practice areas and providing new solutions that address clients’ expanding needs to transform their businesses .

2nd Watch has enabled enterprises to become cloud native since 2011. The company has become the trusted cloud advisor to hundreds of Fortune 500 companies, embracing their unique modernization journey to help transform and modernize their business to achieve true business transformation through cloud adoption.

About 2nd Watch

2nd Watch is an AWS Partner Network Premier Consulting Partner, Google Cloud Partner, and Microsoft Azure Gold Partner, providing professional and managed cloud services to enterprise clients. The company’s subject matter experts and software-enabled services provide companies with tested, proven, and trusted solutions with a focus on six solution areas – Enterprise Cloud Migration, Security and Compliance, Cloud Native and DevOps, Optimization, Data Engineering and Analytics, and Managed Services – allowing them to fully leverage the power of the cloud. 2nd Watch solutions are high performing, robust, increase operational excellence, decrease time to market, accelerate growth and lower risk. 2nd Watch helps enterprises design, deploy and manage cloud solutions and monitors business critical workloads 24×7. The company is headquartered in Seattle, Washington. To learn more about 2nd Watch, visit www.2ndwatch.com.

Media contact:

Kevin Wolf

TGPR

(650) 483-1552

[email protected]

 Graves’ investment joins Chamath Palihapitiya’s Social Capital, Mark Cuban and leading institutional investors

SAN FRANCISCO , Feb. 01, 2021 (GLOBE NEWSWIRE) — Metromile, Inc., a leading digital insurance platform and pay-per-mile auto insurer, today announced Ryan Graves, Uber’s former senior vice president of global operations, intends to make a $50 million investment in the company personally and through his investment firm, Saltwater. Graves’ investment includes secondary purchases and participation in the previously announced PIPE transaction that will close alongside the merger with INSU Acquisition Corp. II (NASDAQ: INAQ). Graves will join Metromile’s board of directors following the business combination’s close.

Graves joins Chamath Palihapitiya’s Social Capital, Mark Cuban, and leading institutional investors to support Metromile’s growth plans as a public company.

Before founding Saltwater, from 2017 to 2019, Graves served on the board of directors of Uber Technologies, Inc. (“Uber”). He was Uber’s first employee, first chief executive officer, and a member of the founding team.

“Ryan has a remarkable reputation as an energetic and thoughtful business builder. His leadership and operating skills made Uber one of the fastest-growing companies of all time. As Metromile accelerates growth and scale, Ryan’s partnership will be immensely valuable to our Board and management team,” said Metromile Founder and Chairman David Friedberg. “We are thrilled to have him become an owner in the business and sit side-by-side our Board and management team as we execute our growth plans as a public company.”

“Metromile has a discipline and long-term orientation reminiscent of Berkshire Hathaway combined with the kind of truly transformative technology that initially attracted me to Uber. The founders and the management team are purpose-driven and have engineered a platform poised to change a massive industry meaningfully,” said Graves. “I spend my time and invest my capital in a concentrated way and aim to be an active partner to businesses that offer the ability to do that for decades to come. With this investment, I’m making the largest professional commitment I’ve made since Uber. Metromile is a rare find.”

“We are thrilled to have Ryan join Metromile,” said Metromile Chief Executive Officer Dan Preston. “He is an incredible operator and investor and appreciates how durable economics enables speed and scale. Ryan shares our belief that the automotive and auto insurance markets are rapidly digitizing, as new modes of transportation, autonomous vehicles and remote work rewrite how these industries will operate. With Ryan’s partnership, we intend to lead that change, helping consumers with fair prices and better experiences, while delivering for our shareholders along the way.”

Metromile, Inc. entered into a business combination agreement with INSU Acquisition Corp. II on November 24, 2020. Upon the business combination’s close, expected during the first quarter of 2021, Metromile, Inc. will become a wholly-owned subsidiary of INSU Acquisition Corp. II, renamed as Metromile Operating Company. INSU Acquisition Corp. II will be renamed Metromile, Inc., and is expected to remain listed on Nasdaq under the new ticker symbol “MILE.”

About Metromile

Metromile is a leading digital insurance platform in the United States. With data science as its foundation, Metromile offers real-time, personalized auto insurance policies by the mile, instead of the industry-standard approximations and estimates that have historically made prices unfair. Metromile’s digitally native offering is built around the modern driver’s needs, featuring automated claims, complimentary smart driving features and annual average savings of 47% over what they were paying their previous auto insurer.

In addition, through Metromile Enterprise, it licenses its technology platform to insurance companies around the world. This cloud-based software as a service enables carriers to operate with greater efficiency, automate claims to expedite resolution, reduce losses associated with fraud, and unlock the productivity of employees. 

For more information about Metromile, visit www.metromile.com and enterprise.metromile.com.

Important Information for Investors and Stockholders

In connection with the Business Combination between Metromile and INSU II, INSU II has filed with the SEC a definitive proxy statement / prospectus and has mailed a definitive proxy statement / prospectus and other relevant documentation to INSU II stockholders. This document does not contain all the information that should be considered concerning the Business Combination. It is not intended to form the basis of any investment decision or any other decision in respect to the Business Combination. INSU II stockholders and other interested persons are advised to read the definitive proxy statement / prospectus in connection with INSU II’s solicitation of proxies for the special meeting to be held to approve the transactions contemplated by the proposed business combination because these materials will contain important information about Metromile, INSU II and the proposed transactions. The definitive proxy statement / prospectus was mailed to INSU II stockholders as of the Record Date. 

This document shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed business combination.

Participants in the Solicitation

INSU II, Metromile, and their respective directors and officers may be deemed participants in the solicitation of proxies of INSU II stockholders in connection with the proposed business combination. INSU II stockholders and other interested persons may obtain, without charge, more detailed information regarding the directors and officers of INSU II and of Metromile in INSU II’s definitive proxy statement / prospectus.

Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to INSU II stockholders in connection with the proposed business combination is set forth in the definitive proxy statement / prospectus. Additional information regarding the interests of participants in the solicitation of proxies in connection with the proposed transaction is included in the definitive proxy statement / prospectus.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “will,” “intend,” “expect,” “anticipate,” “believe,” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, expectations related to the terms and timing of completing the transaction. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Metromile’s and INSU II’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Metromile and INSU II. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political and legal conditions; the inability of the parties to successfully or timely consummate the Business Combination, including the risk that any required  approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the Business Combination or that the approval of the stockholders of INSU II is not obtained; and those factors discussed in INSU II’s final prospectus filed on September 4, 2020,  Quarterly Report on Form 10-Q for the quarter ended  September 30, 2020 and the Registration Statement, and the definitive proxy statement/prospectus contained therein, in each case, under the heading “Risk Factors,” and other documents of INSU II filed, or to be filed, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither INSU II nor Metromile presently know or that INSU II and Metromile currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect INSU II’s and Metromile’s expectations, plans or forecasts of future events and views as of the date of this press release. INSU II and Metromile anticipate that subsequent events and developments will cause INSU II’s and Metromile’s assessments to change. However, while INSU II and Metromile may elect to update these forward-looking statements at some point in the future, INSU II and Metromile specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing INSU II’s and Metromile’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Contacts

Investor Relations

Garrett Edson, ICR
[email protected]
646-677-1889

Public Relations

Rick Chen, Metromile
Doug Donsky, ICR
[email protected]
415-676-7744

INSU II and Cohen & Company

Amanda Abrams
[email protected]
215-701-9693

###

Attachment

• Ryan Graves

• It is the first extrafine fixed triple combination therapy in a single inhaler to be approved for use in asthma patients. This follows the 2017 approval of this therapeutic option for the treatment of Chronic Obstructive Pulmonary Disease (COPD).¹
• The Marketing Authorization approval is based on CHMP positive opinion and European Commission approval on data obtained in 4 clinical studies involving close to 3,000 patients.

PARMA, Italy, Feb. 01, 2021 (GLOBE NEWSWIRE) — Chiesi, an international research-focused Healthcare group (Chiesi Group), announces that the European Commission has granted the marketing authorization for Chiesi extrafine triple therapy combination ICS/LABA/LAMA in a single inhaler, for the treatment of asthma. This follows the 2017 approval of this therapeutic option for the treatment of Chronic Obstructive Pulmonary Disease (COPD).¹

The triple therapy is a combination of Inhaled Corticosteroid (ICS) / Long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) that contains Beclometasone dipropionate (BDP; inhaled corticosteroid), Formoterol fumarate (FF; long-acting β2 agonist) and Glycopyrronium (G; long-acting muscarinic antagonist).^1,2 Chiesi triple therapy for asthma is the first extrafine triple combination able to reach and treat the whole bronchial tree, including small airways.^2,3 Chiesi’s Modulite extrafine particle technology potentially facilitating coordination of inhalation.^4,5

The product is provided with a dose counter that allow patients to track and manage their treatment efficiently.²

“This is the first step towards taking our triple therapy for COPD patients and providing the same treatment option for Asthma patients,” said Alessandro Chiesi, Chiesi Group Chief Commercial Officer. “Chiesi is committed to developing and delivering alternatives to aid patients in the management of their respiratory conditions and treatment. The European Commission approval brings us one step closer to providing uncontrolled asthma patients with new treatment options for their care, reducing exacerbations and potentially simplifying the use for patients thanks to a single inhaler triple therapy.”

Asthma is a chronic inflammatory disease affecting over 339 million people worldwide.⁶ According to GINA Report, people with uncontrolled asthma have poor symptom control and/or frequent exacerbations requiring oral corticosteroids or experience serious exacerbations requiring hospitalization.⁷  

In patients with uncontrolled asthma, Chiesi triple therapy has been shown to reduce exacerbations and improve lung function in comparison to ICS/LABA (Inhaled Corticosteroid / Long-acting beta-agonist).⁴

The CHMP recommendation and the European Commission decision are based on the efficacy and safety data of 4 clinical studies involving close to 3,000 patients.

About Chiesi Group

Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused healthcare group with 85 years of experience in the pharmaceutical industry and a global presence in 29 countries. Chiesi researches, develops, and markets innovative drugs in the respiratory therapeutics, specialist medicine, and rare disease areas. Its R&D organization is headquartered in Parma (Italy), and is integrated with R&D groups in France, the USA, the UK and Sweden to advance Chiesi’s pre-clinical, clinical and registration programs. Chiesi employs over 6,000 people. Chiesi Group is a certified Benefit corporation. For more information, please visit www.chiesi.com.

About Chiesi triple therapy

Chiesi triple therapy is the first extrafine fixed triple combination of Inhaled Corticosteroid (ICS) / Long-acting β2-agonist (LABA) / long-acting muscarinic antagonist (LAMA) that contains Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium (G). Trimbow will be available as twice a day pMDI (pressurized metered dose inhaler) to be licensed for maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and a medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. Chiesi triple therapy is also approved in COPD as maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist.²

About Asthma

Asthma is a common long-term condition that can affect people of all ages and causes inflammation in the airways. The prevalence of asthma in the European Union (EU) is 8.2% in adults and 9.4% in children. Difficult-to-treat, or severe asthma occurs in 24% of patients. The direct and indirect costs of asthma to societies are substantial. Recent calculations estimate direct costs within the EU to be nearly €20 billion, indirect costs to be €14 billion and a monetised value of DALYs lost to be €38 billion, which totals €72 billion.⁸

For further information: 

Valentina Biagini, Senior Global Communication Manager
Mobile: +39 348 7693 623
E-mail: [email protected]

References

1. Trimbow, EMEA/H/C/004257, EMA marketing authorisation valid throughout the European Union, approved 17/07/2017, https://www.ema.europa.eu/en/medicines/human/EPAR/trimbow#authorisation-details-section
2. Trimbow SmPC
3. Usmani et al., JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 2020 Pp. 1–8
4. JC Virchow et al., Lancet 2019; 394: 1737–49
5. Nicolini at al. – The Clin Risk Manag 2008; 4(5):855-864
6. WHO, Asthma Facts: https://www.who.int/news-room/fact-sheets/detail/asthma
7. GINA, Difficult-to-treat & severe asthma in adolescent and adult patients, Diagnosis Management, A GINA Pocket Guide for Health Professionals, 2019, https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf
8. Selroos O et al. National and regional asthma programmes in Europe. Eur Respir Rev 2015; 24: 474–483

PDF available: http://ml.globenewswire.com/Resource/Download/f6ad6d98-5182-4de7-b691-adbd75eab36e

CHICAGO and BURLINGTON, Mass., Feb. 01, 2021 (GLOBE NEWSWIRE) — The National Basketball Retired Players Association (NBRPA) and Flexion Therapeutics Inc. today announced a new partnership to raise awareness of osteoarthritis-related knee pain and present ZILRETTA (triamcinolone acetonide extended-release injectable suspension) as an effective treatment option. The educational program tipped off with a virtual event featuring Sheryl Swoopes, basketball Hall of Famer and ZILRETTA patient, discussing how osteoarthritis (OA) of the knee has impacted her life and how ZILRETTA has helped with pain management. Swoopes is the first athlete from the WNBA to participate in the awareness program. The partnership with Swoopes complements Flexion’s relationship with ZILRETTA Athlete Ambassadors, NFL Hall of Famer Rod Woodson and 1980 USA hockey team captain and gold medal winner Mike Eruzione.

“We are excited to partner with the NBRPA to raise awareness of knee OA and ZILRETTA, and we are truly honored to be working with Sheryl, a world-class athlete who continues to exemplify greatness well after the height of her career,” said Michael Clayman, M.D., President and Chief Executive Officer of Flexion. “As one of the most exceptional women athletes of all time, a hall of famer, and three-time Olympic gold medalist, Sheryl knows about pushing the limits physically, and we are very pleased that she has finally found the much-needed relief from her OA knee pain with ZILRETTA.”

Swoopes, the first player to be signed in the WNBA, is a three-time WNBA MVP and was named one of the league’s Top 15 Players of All Time at the 2011 WNBA All-Star Game. She won three Olympic gold medals and is one of 10 women’s basketball players to have won an Olympic gold medal, an NCAA Championship and a WNBA title. She was elected to the Naismith Memorial Basketball Hall of Fame in 2016 and is an active leader in the NBRPA.

“The best partnerships are all about authenticity, and we found out through a survey of our membership that knee pain ranked among retired players’ top ailments following their careers,” said Scott Rochelle, NBRPA’s Executive Director. “There is no better, more engaged advocate for those suffering OA knee pain and no stronger advocate to speak to the benefits of ZILRETTA than Sheryl. We look forward to growing this relationship in the coming months to be one of our most inclusive and informative to date.”

Swoopes added, “I fully understand the way OA knee pain can impact your life in every aspect, not just physically but mentally. To be able to tell my story and share the results of what can be done with treatment with my colleagues, friends, former players and family is very important. This partnership will not only help many of the athletes who have played in the NBA and WNBA, but it will serve to raise awareness for thousands who may be suffering in silence.”

Swoopes was treated by Rabah Qadir, M.D., a fellowship-trained orthopedic surgeon at the Woodlands Sports Medicine Center and Chairman of Orthopedic Surgery at Memorial Hermann Woodlands Medical Center in the Houston area. Dr. Qadir said, “While Sheryl has enjoyed the career of an elite athlete, unfortunately, her experience with OA knee pain is far from unique. Knee injuries, especially cartilage and meniscus injuries, are common for basketball players and can lead to OA over time. After evaluating Sheryl and understanding her desire to stay active with a non-surgical treatment plan, ZILRETTA was an obvious choice to offer Sheryl the extended pain relief she needed.”

More information on how to find a treating physician can be found at https://www.getthez.com or by calling 888-600-GETZ (4389).

The NBRPA represents over 1,000 former NBA and WNBA players, making it the largest agency of its kind in basketball. This has allowed for direct access to players for opportunities to educate other members and their treating physicians.

Indication and Important Safety Information for ZILRETTA

Indication: ZILRETTA is indicated as an intra-articular injection for the management of OA pain of the knee.

Limitation of Use: The efficacy and safety of repeat administration of ZILRETTA have not been demonstrated.

Contraindication: ZILRETTA is contraindicated in patients who are hypersensitive to triamcinolone acetonide, corticosteroids or any components of the product.

Warnings and Precautions:

• Intra-articular Use Only: ZILRETTA has not been evaluated and should not be administered by epidural, intrathecal, intravenous, intraocular, intramuscular, intradermal, or subcutaneous routes. Serious events have been reported with epidural and intrathecal administration of corticosteroids and none are approved for this use. ZILRETTA should not be considered safe for epidural or intrathecal administration.
   
• Hypersensitivity Reactions: Rare instances of anaphylaxis, including serious cases, have occurred in patients with hypersensitivity to corticosteroids.
   
• Joint Infection and Damage: A marked increase in pain accompanied by local swelling, restriction of joint motion, fever, and malaise are suggestive of septic arthritis. Examine joint fluid to exclude a septic process. If diagnosis is confirmed, institute appropriate antimicrobial therapy. Avoid injecting corticosteroids into a previously infected or unstable joint. Intra-articular administration may result in damage to joint tissues.
   
• Increased Risk of Infections: Infection with any pathogen in any location of the body may be associated with corticosteroid use. Corticosteroids may increase the susceptibility to new infection and decrease resistance and the ability to localize infection.
   
• Alterations in Endocrine Function: Corticosteroids can produce reversible hypothalamic-pituitary-adrenal axis suppression, with potential for adrenal insufficiency after withdrawal of treatment, which may persist for months. In situations of stress during that period, institute corticosteroid replacement therapy.
   
• Cardiovascular and Renal Effects: Corticosteroids can cause blood pressure elevation, salt and water retention, and increased potassium excretion. Monitor patients with congestive heart failure, hypertension, and renal insufficiency for edema, weight gain, and electrolyte imbalance. Dietary salt restriction and potassium supplementation may be needed.
   
• Increased Intraocular Pressure: Corticosteroid use may be associated with increased intraocular pressure. Monitor patients with elevated intraocular pressure for potential treatment adjustment.

• Gastrointestinal Perforation: Corticosteroid administration may increase risk of gastrointestinal perforation in patients with certain GI disorders and fresh intestinal anastomoses. Avoid corticosteroids in these patients.
   
• Alterations in Bone Density: Corticosteroids decrease bone formation and increase bone resorption. Special consideration should be given to patients with or at increased risk of osteoporosis prior to treatment.
   
• Behavior and Mood Disturbances: Corticosteroids may cause adverse psychiatric reactions. Prior to treatment, special consideration should be given to patients with previous or current emotional instability or psychiatric illness. Advise patients to immediately report any behavior or mood disturbances.

Adverse Reactions

The most commonly reported adverse reactions (incidence ≥1%) in clinical studies included sinusitis, cough, and contusions.

Please see 

ZilrettaLabel.com

 for full Prescribing Information.

About the National Basketball Retired Players Association:

The National Basketball Retired Players Association (NBRPA) is comprised of former professional basketball players from the NBA, ABA, WNBA and Harlem Globetrotters. It is a 501(c) 3 organization with a mission to develop, implement and advocate a wide array of programs to benefit its members, supporters and the community. The NBRPA was founded in 1992 by basketball legends Dave DeBusschere, Dave Bing, Archie Clark, Dave Cowens and Oscar Robertson. The NBRPA works in direct partnerships with the NBA and the National Basketball Players Association. Legends Care is the charitable initiative of the NBRPA that positively impacts youth and communities through basketball. Scott Rochelle is President and CEO, and the NBRPA Board of Directors includes Chairman of the Board Johnny Davis, Treasurer Sam Perkins, Secretary Grant Hill, Thurl Bailey, Caron Butler, Dave Cowens, Shawn Marion, David Naves and Sheryl Swoopes. Learn more at legendsofbasketball.com.

About Flexion Therapeutics

Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company’s core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.

About ZILRETTA

On October 6, 2017, ZILRETTA was approved by the U.S. FDA as the first and only extended-release intra-articular therapy for patients confronting OA-related knee pain. ZILRETTA employs proprietary microsphere technology combining triamcinolone acetonide—a commonly administered, short-acting corticosteroid—with a poly lactic-co-glycolic acid (PLGA) matrix to provide extended pain relief. The pivotal Phase 3 trial on which the approval of ZILRETTA was based showed that ZILRETTA significantly reduced OA knee pain for 12 weeks, with some people experiencing pain relief through Week 16. Learn more at www.zilretta.com.

Media Contacts:

NBRPA:
Joe Favorito
T: 917-566-8345
[email protected]

Julio Manteiga
T: 516-749-9894
[email protected]

Flexion Therapeutics:
Scott Young
T: 781-305-7194
[email protected]

Julie Downs
T: 781-305-7137
[email protected]

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/bcbf0259-aa32-408d-8a3b-f70b6ea02375

https://www.globenewswire.com/NewsRoom/AttachmentNg/b83cf1fc-c37e-41a5-85ba-f083ed2eef2d

BEDMINSTER, NJ, Feb. 01, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) (the “Company”) announces its fourth quarter and full year 2020 results. 

This earnings release should be read in conjunction with the Company’s

Q4 2020 Investor Update (and Supplemental Financial Information), a copy of which is available on our website at



www.pgbank.com



and

via a current report on Form 8-K on the website of the Securities and Exchange Commission at
www.sec.gov
.  

The Company recorded total revenue of $189.36 million, net income of $26.19 million and diluted earnings per share (“EPS”) of $1.37 for the year ended December 31, 2020, compared to $174.97 million, $47.43 million and $2.44, respectively, for the year ended December 31, 2019. 

The main driver of the decrease in net income and EPS for the 2020 twelve-month period was a $32.40 million provision for loan losses due to the current environment created by the COVID-19 pandemic, which led to increased qualitative loss factors when calculating the allowance for loan losses. This $32.40 million compared to a $4.00 million provision for the 2019 twelve-month period.   

The 2020 twelve-month period included increased net interest income and noninterest income. The increase in net interest income was due principally to earnings from the Paycheck Protection Program (“PPP”). The increase in noninterest income also benefitted from gain on sale of PPP loans and increases in wealth management income (primarily due to the acquisition of Point View Wealth Management acquired in September 2019) and mortgage banking income. These increases were partially offset by increased operating expenses (due in part to the previous mentioned firm acquired in September 2019, prepayment of FHLB advances, valuation allowance for a loan held for sale, the closure of one retail branch and consolidation of two private banking locations). 

The 2020 twelve-month period also included a tax benefit of $3.2 million recorded in the first quarter of 2020 caused by the changes in the treatment of tax net operating losses (“NOL”) under the provisions of the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act.   

For the quarter ended December 31, 2020, the Company recorded total revenue of $46.14 million, net income of $3.03 million and EPS of $0.16, compared to $46.44 million, $12.23 million and $0.64, respectively, for the same three-month period last year. 

The 2020 quarter included increased net interest income, due in part to earnings from the PPP, but also due to increased other interest-earnings assets.  Noninterest income also increased due to increases in wealth management income and mortgage banking income.  These increases were partially offset by increased operating expenses (due in part to the previous mentioned prepayment of FHLB advances ($4.78 million), valuation allowance for loan held for sale ($4.43 million) and consolidation of two private banking offices ($210,000), and an increase in the provision for loan and lease losses to $2.35 million due to the current environment created by the COVID-19 pandemic, compared to a $1.95 million provision for loan and lease losses for the 2019 quarter.   

On January 28, 2021, the Company authorized the repurchase of up to 948,735 shares, or approximately 5% of its outstanding shares, through March 31, 2022. Purchases will be conducted in accordance with the limitations set forth in the SEC’s Rule 10b-18.  

Douglas L. Kennedy, President and CEO, said, “Our capital is strong and believe that purchasing our Company’s stock is an opportunity for us to effectively manage our excess capital, while taking advantage of the Company’s discounted valuation relative to peers.”

Mr. Kennedy also said, “As noted in previous quarters, during 2020 we generally allowed our commercial and business clients to have their loan deferred for a six-month period. As of June 30, 2020, our deferrals stood at $914 million. As of September 30, 2020, deferrals were $828 million. As of December 31, 2020, our deferrals were $74 million (or 1.7% of the loan portfolio).” 

For more information about the Company’s loan deferrals, including a breakdown by loan type and industry, as well as detail concerning our loan exposure to industries, please see the Q4 2020 Investor Update (and Supplemental Financial Information). 

EXECUTIVE SUMMARY:

The following tables summarize specified financial measures for the periods shown. 

Year over Year Comparison

		Year Ended				Year Ended
		December 31,				December 31,					Increase/
(Dollars in millions, except per share data)		2020				2019					(Decrease)
Net interest income		$	127.60			$	120.27				$	7.33				6	%
Wealth management fee income (A)			40.86				38.36					2.50				7
Capital markets activity (B)			6.65				8.67					(2.02	)			(23	)
Other income (C)			14.25				7.67					6.58				86
Total other income			61.76				54.70					7.06				13
Operating expenses (D)			124.96				104.85					20.11				19
Pretax income before provision for loan losses			64.40				70.12					(5.72	)			(8	)
Provision for loan and lease losses (E)			32.40				4.00					28.40				710
Pretax income			32.00				66.12					(34.12	)			(52	)
Income tax expense (F)			5.81				18.69					(12.88	)			(69	)
Net income		$	26.19			$	47.43				$	(21.24	)			(45	)%
Diluted EPS		$	1.37			$	2.44				$	(1.07	)			(44	)%
Total Revenue		$	189.36			$	174.97				$	14.39				8	%
Return on average assets annualized			0.45	%			0.99	%				(0.54	)
Return on average equity annualized			5.11	%			9.70	%				(4.59	)

1. The twelve months ended December 31, 2020 included wealth management fee income and expense related to Point View Wealth Management, (“Point View”), which was acquired effective September 1, 2019.  
2. Capital markets activity includes loan level back-to-back swap activities, the SBA lending and sale program, and mortgage banking activities. There were $1.6 million of fees related to loan level back-to-back swap activities in 2020 period, compared to $5.8 million in 2019.  
3. The twelve months ended December 31, 2020 includes a gain on sale of $7.4 million on the sale of $355 million of PPP loans.
4. The twelve months ended December 31, 2020 includes a full year of operating expenses related to Point View, $4.8 million for the prepayment of FHLB advances, $4.4 million for the valuation allowance for a loan held for sale, $210,000 for the consolidation of two private banking locations, $278,000 for the closure of a retail branch, and an increase in FDIC premium expense due to credits applied in 2019 available to the banking industry but unavailable in general. 
5. The twelve months ended December 31, 2020 included a provision for loan and lease losses of $32.40 million, which was primarily due to the current environment created by the COVID-19 pandemic. 
6. The 2020 period included a $3.2 million tax benefit related to the carryback of tax NOLs to prior years when the Federal tax rate was 14% higher.

December 2020 Quarter Compared to Prior Year Quarter

		Three Months Ended					Three Months Ended
		December 31,					December 31,				Increase/
(Dollars in millions, except per share data)		2020					2019				(Decrease)
Net interest income		$	31.74				$	30.91			$	0.83				3	%
Wealth management fee income			10.79					10.12				0.67				7
Capital markets activity (A)			1.85					3.73				(1.88	)			(50	)
Other income			1.76					1.68				0.08				5
Total other income			14.40					15.53				(1.13	)			(7	)
Operating expenses (B)			39.25					26.70				12.55				47
Pretax income before provision for loan losses			6.89					19.74				(12.85	)			(65	)
Provision for loan and lease losses (C)			2.35					1.95				0.40				21
Pretax income			4.54					17.79				(13.25	)			(74	)
Income tax expense			1.51					5.56				(4.05	)			(73	)
Net income		$	3.03				$	12.23			$	(9.20	)			(75	)%
Diluted EPS		$	0.16				$	0.64			$	(0.48	)			(76	)%
Total Revenue		$	46.14				$	46.44			$	(0.30	)			(1	)%
Return on average assets annualized			0.21	%				0.98	%			(0.77	)
Return on average equity annualized			2.32	%				9.81	%			(7.49	)

1. Capital markets activity includes loan level back-to-back swap activities, the SBA lending and sale program, and mortgage banking activities. There were no fees related to loan level back-to-back swap activities in the quarter ended December 31, 2020, compared to $2.5 million in the December 2019 quarter.  
2. The quarter ended December 31, 2020 includes $4.8 million for the prepayment of FHLB advances, $4.4 million for the valuation allowance for a loan held for sale, $210,000 for the consolidation of two private banking locations, and an increase in FDIC premium expense due to credits applied in the 2019 period that were available to the banking industry in general.
3. The December 2020 quarter included a provision for loan and lease losses of $2.35 million.

December 2020 Quarter Compared to Linked Quarter

		Three Months Ended				Three Months Ended
		December 31,				September 30,					Increase/
(Dollars in millions, except per share data)		2020				2020					(Decrease)
Net interest income		$	31.74			$	32.15				$	(0.41	)			(1	)%
Wealth management fee income			10.79				10.12					0.67				7
Capital markets activity (A)			1.85				1.03					0.82				80
Other income (B)			1.76				9.06					(7.30	)			(81	)
Total other income			14.40				20.21					(5.81	)			(29	)
Operating expenses (C)			39.25				28.46					10.79				38
Pretax income before provision for loan losses			6.89				23.90					(17.01	)			(71	)
Provision for loan and lease losses (D)			2.35				5.15					(2.80	)			(54	)
Pretax (loss)/income			4.54				18.75					(14.21	)			(76	)
Income tax expense			1.51				5.20					(3.69	)			(71	)
Net income		$	3.03			$	13.55				$	(10.52	)			(78	)%
Diluted EPS		$	0.16			$	0.71				$	(0.55	)			(77	)%
Total Revenue		$	46.14			$	52.36				$	(6.22	)			(12	)%
Return on average assets annualized			0.21	%			0.89	%				(0.68	)
Return on average equity annualized			2.32	%			10.53	%				(8.21	)

1. Capital markets activity includes loan level back-to-back swap activities, the SBA lending and sale program, and mortgage banking activities.  
2. The quarter ended September 30, 2020 includes a gain on sale of $7.4 million on the sale of $355 million of PPP loans.
3. The quarter ended December 31, 2020 includes $4.8 million for the prepayment of FHLB advances, $4.4 million for the valuation allowance for a loan held for sale and $210,000 for the consolidation of two private banking locations.
4. The provision for loan and lease losses for the three months ended December 31, 2020 was less than the provision for the three months ended September 30, 2020 as certain qualitative factors related to COVID-19 pandemic were partially reduced.  

The Company’s near-term priorities include:

• Actively deploy/manage capital and liquidity by expanding our lending activities and execution on our recently announced stock repurchase program. 
• Grow and expand our core wealth management and commercial banking businesses, including lift-outs, strategic hires, and acquisition of wealth management firms. 
• Expand our net interest margin. 
• Continue to assess the economic recovery; modify our allowance for credit losses as justified given the economic environment. 
• Invest in digital enhancements to improve the client acquisition and experience.
• Grow fee income to 35% to 45% of total bank revenue. 

Other select highlights for the quarter included:

• As previously announced, in the fourth quarter of 2020 the Company successfully completed a private placement of $100 million in fixed-to floating rate subordinated notes due 2030 at a rate of 3.5%. The proceeds raised will be used for general corporate purposes, which will include stock repurchases and could potentially include redemption of the Company’s existing 6% subordinated debt and acquisitions of wealth management firms.   
• As previously announced, the Company repaid $105 million of FHLB advances at a cost of $4.8 million, which will provide a benefit to interest expense greater than the prepayment penalty over the remaining life of the advances.
• As previously announced, effective in December 2020 the Company completed its lift out of teams from Lucas Capital Management, a registered investment advisor headquartered in Red Bank, NJ, which added nearly $250 million of assets under management and/or administration (“AUM/AUA”) and Noyes Capital Management, a registered investment advisor headquartered in New Vernon, NJ, which added approximately $150 million of AUM/AUA.
• The Company recorded $210,000 of charges related to the consolidation of two private banking locations.   The Company expects to recoup the charges in less than a year.
• Wealth management fee income, which comprised approximately 22% of the Company’s total revenue for the twelve-months ended December 31, 2020, continues to contribute significantly to the Company’s diversified revenue sources. 
• As of December 31, 2020, total C&I loans (including PPP and loans held for sale) comprised 45% of the total loan portfolio.  
• Deposits totaled $4.82 billion at December 31, 2020.  This reflected net growth of $575 million or 14% compared to $4.24 billion at December 31, 2019.  
• The Company’s reported and core net interest margin improved in the quarter when compared to the September 2020 quarter. (See subsequent discussion of Net Interest Income / Net Interest Margin)
• In addition to $1.3 billion (22% of total assets) of balance sheet liquidity (investments, interest-earning deposits and cash) as of December 31, 2020, the Company also has access to approximately $2.7 billion of available secured funding at the Federal Home Loan Bank and the Federal Reserve. 
• The Company’s and Bank’s capital ratios at December 31, 2020 remain strong and the Company’s tangible book value per share at December 31, 2020 was $25.47 (compared to a book value of $27.78), reflecting an increase of over 4% from $24.47 (compared to a book value of $26.61) at December 31, 2019, despite a much higher than normal provision for loan and lease losses during 2020 ($32.4 million in 2020 compared to $4.0 million in 2019).  
• Nonperforming assets at December 31, 2020 were $11.5 million, or 0.19% of total assets. Loans past due 30 to 89 days total $5.1 million at December 31, 2020.     

SUPPLEMENTAL QUARTERLY DETAILS
:

Wealth Management Business

In the December 2020 quarter, the Bank’s wealth management business generated $10.79 million in fee income, compared to $10.12 million for the December 2019 quarter, and $10.12 million for the September 2020 quarter. 

The market value of the Company’s AUM/AUA increased from $7.6 billion at September 30, 2020 to a record $8.8 billion at December 31, 2020. 

In the December 2020 quarter the Company completed the lift out of teams from Lucas Capital Management and Noyes Capital Management which combined added approximately $400 million in AUM/AUA.

John P. Babcock, President of the Peapack Private Wealth Management division, said “2020 new business, new client acquisition and client retention were all strong and aided by favorable market action in the second half of the year, most notably in the quarter ended December 31, 2020.  2020 full year gross inflows totaled over $600 million”. Babcock went on to note, “We continue to look to grow our wealth business organically and through selective acquisition.  At year-end 2020, we combined two of our acquired RIAs – Lassus Wherley Associates and Point View Wealth Management into the Peapack Private bank entity and we continue to make significant progress on our infrastructure consolidation including launching our new trading platform and a new CRM system, as well as adding more resources to our financial planning team.”

Loans / Commercial Banking 

Total loans of $4.40 billion at December 31, 2020 (including PPP loans of $196 million) were relatively flat when compared to the December 31, 2019 balance, and declined $54 million from $4.46 billion at September 30, 2020, as paydown and payoff activity remains robust. Excluding PPP loan originations of $596 million, 2020 origination levels of approximately $885 million were less than 2019’s level of $1.3 billion, due to the impact of the COVID-19 pandemic in 2020. 

Total C&I loans (including $196 million of PPP loans) at December 31, 2020 were $1.98 billion.  This reflected net growth of $199 million when compared to $1.78 billion at December 31, 2019.  Excluding the $196 million of PPP loans at December 31, 2020, total C&I loans remained relatively flat in 2020 despite paydowns of several large lines of credit, as well as the Company’s workout and asset recovery efforts, including the workout and recovery of several nonaccrual and/or classified credits during the latter part of 2020. 

Although the Bank sold $355 million of PPP loans in the third quarter of 2020 (at a gain of $7.4 million), as of December 31, 2020, the Bank still held $196 million of PPP loans (almost all of which exceed $2.0 million in original principal amount) with approximately $1.2 million of net deferred fees which will be recognized into income over the remaining portion of the original two-year maturity of the loan or as forgiven or repaid. 

The Company maintains a well-diversified loan portfolio, by loan type and by industry concentration, as detailed in the Q4 2020 Investor Update (and Supplemental Financial Information).

Mr. Kennedy noted, “Our commercial pipelines going into the new year are strong. Further, and as I noted in prior periods, our Corporate Advisory business, which gives us the capability to engage in high level strategic debt, capital and valuation analysis, enables us to provide a unique boutique level of service, giving us a competitive advantage over many of our peers. Our Corporate Advisory pipelines are also strong.”

Funding / Liquidity / Interest Rate Risk Management

The Company actively manages its deposit base to reduce reliance on wholesale sourced deposits, volatility, and/or operational risk. Total deposits at December 31, 2020 were $4.82 billion reflecting an increase of $575 million when compared to $4.24 billion at December 31, 2019. Noninterest bearing demand deposits increased $304 million, interest bearing demand increased $339 million, brokered deposits declined $70 million, and higher costing CDs declined $119 million.  Mr. Kennedy noted, “Of our total deposits, only 17% are not covered by FDIC insurance, reinforcing the “core” nature of our deposit base.”

For the quarter ended December 31, 2020, the Company’s balance sheet liquidity (investments, interest-earning deposits and cash) totaled $1.3 billion (or 22% of assets).  In addition to the $1.3 billion of balance sheet liquidity, the Company also had approximately $1.8 billion of secured funding available from the Federal Home Loan Bank. Additionally, the Company also had $988 million of secured funding available from the Federal Reserve Discount Window. As noted previously, during the fourth quarter of 2020, the Bank prepaid $105 million of FHLB advances with an average rate in excess of 3%. 

Mr. Kennedy noted, “As a commercial bank, a large portion of our loans reprice when the Fed changes rates. The 150-basis point reduction in target Fed Funds near the end of the first quarter of 2020 reduced the Company’s yield earned on assets. However, we were able and continue to strategically reprice our deposits over time to offset much of that decline. Further, when interest rate rise, our net interest income will improve. Our current modeling indicates that net interest income would improve 8.5% with an immediate 100 basis points rise in rates.” 

Net Interest Income (NII)/Net Interest Margin (NIM)

	Twelve Months Ended								Twelve Months Ended
	December 31, 2020								December 31, 2019
	NII				NIM				NII				NIM
NII/NIM excluding the below	$	123,099			2.58%				$	119,032			2.67%
Prepayment premiums received on loan paydowns		1,452			0.02%					1,328			0.03%
Effect of maintaining excess interest earning cash		(1,320	)		-0.21%					(86	)		-0.07%
Effect of PPP loans		4,371			-0.08%					—			0.00%
NII/NIM as reported	$	127,602			2.31%				$	120,274			2.63%
	Three Months Ended								Three Months Ended								Three Months Ended
	December 31, 2020								September 30, 2020								December 31, 2019
	NII				NIM				NII				NIM				NII				NIM
NII/NIM excluding the below	$	30,897			2.51%				$	30,327			2.45%				$	30,385			2.61%
Prepayment premiums received on loan paydowns		413			0.02%					104			0.01%					414			0.03%
Effect of maintaining excess interest earning cash		(206	)		-0.24%					(266	)		-0.24%					115			-0.04%
Effect of PPP loans		631			-0.04%					1,984			-0.02%					—			0.00%
NII/NIM as reported	$	31,735			2.25%				$	32,149			2.20%				$	30,914			2.60%

As shown above, the Company’s reported NIM increased 5 basis points compared to the linked quarter, while core NIM increased 6 basis points compared to the linked quarter. The Bank was able to strategically price down its cost of funds by 7 basis points during the December 2020 quarter. 

Future net interest income will be benefitted by the repricing of the Company’s time certificates of deposit (“CDs”). Over the next 12-months, approximately $460 million of CDs with an average rate of approximately 1.18% will mature. 

Other Noninterest Income (other than Wealth Management fee income) 

Noninterest income from Capital Markets activities (loan level back-to-back swap activities, the SBA lending and sale program, and mortgage banking income) totaled $1.85 million for the December 2020 quarter compared to $1.03 million for the September 2020 quarter and $3.73 million for the December 2019 quarter.  The December 2020 and September 2020 quarters reflected increased mortgage banking activity due to greater refinance activity in the current low rate environment. The higher mortgage banking activity was offset by a significant decrease in loan level back-to-back swap activities, as there has been, and will continue to be, minimal activity for such in the current environment.  

Operating Expenses

The Company’s total operating expenses were $39.25 million for the quarter ended December 31, 2020, compared to $28.46 million for the September 2020 quarter and $26.70 million for the December 2019 quarter.  The December 2020 quarter included the prepayment of FHLB advances ($4.8 million), a valuation allowance on a loan held for sale ($4.4 million) and consolidation of two private banking offices ($210,000).  FDIC insurance expense increased to $665,000 in the December 2020 quarter from $605,000 in the September 2020 quarter and the Company recorded none in the December 2019 quarter.  The increase in FDIC expense in 2020 quarter was due to average asset growth. There was no FDIC insurance expense in the December 2019 quarter due to credits applied which were available to the banking industry in general. The 2020 periods also included reduced deferral of expenses directly related to loan originations when compared to 2019 periods, due to reduced 2020 loan origination levels as a result of the impact of the COVID-19 pandemic.   

Mr. Kennedy noted, “While we continue to manage expenses closely and prudently, we will invest in digital enhancements to improve the client experience and grow and expand our core wealth management and commercial banking businesses, including lift-outs, strategic hires, and wealth M&A.”

Income Taxes

The effective tax rate for the three months ended December 31, 2020 was 33.29%, as compared to 27.75% for the September 2020 quarter and 31.23% for the December 2019 quarter. A tax return to book adjustment recorded in the December 2020 quarter, coupled with reduced pretax income in the that quarter, increased the December 2020 effective tax rate by approximately 5%.     

During the first quarter of 2020, the Company recorded a $3.34 million tax benefit, principally due to a $3.2 million Federal income tax benefit that resulted from a tax NOL carryback. The Company had a $23 million operating loss for tax purposes in 2018 (when the Federal tax rate was 21%) resulting from accelerated tax depreciation. Under the CARES Act, the Company was allowed to carry this NOL back to a period when the Federal tax rate was 35%, generating a permanent tax benefit.  

Asset Quality / Provision for Loan and Lease Losses

For further details, see the Q4 2020 Investor Update (and Supplemental Financial Information).

Nonperforming assets at December 31, 2020 (which does not include troubled debt restructured loans that are performing in accordance with their terms) were $11.5 million, or 0.19% of total assets, up slightly from $8.7 million, or 0.15% of total assets, at September 30, 2020 and down significantly from $28.9 million, or 0.56% of total assets, at December 31, 2019.  Total loans past due 30 through 89 days and still accruing were $5.1 million at December 31, 2020 (of which $4.7 million made their past due payments in January), compared to $6.6 million at September 30, 2020 and $1.9 million at December 31, 2019.  During the third and fourth quarter of 2020, the Company’s asset recovery and workout efforts reduced nonperforming and classified assets.    

For the quarter ended December 31, 2020, the Company’s provision for loan and lease losses was $2.35 million compared to $5.15 million for the September 2020 quarter and $1.95 million for the December 2019 quarter. The increased provision for loan and lease losses in the 2020 quarters when compared to the 2019 quarter reflect the current environment created by the COVID-19 pandemic, which led to increased qualitative loss factors when calculating the allowance for loan losses. The Company’s provision for loan and lease losses (and its allowance for loan and lease losses) also reflect, among other things, the Company’s assessment of asset quality metrics, net loan decline, net charge-offs/recoveries, and the composition of the loan portfolio. 

At December 31, 2020, the allowance for loan and lease losses was $67.31 million (1.53% of total loans), compared to $66.15 million at September 30, 2020 (1.48% of total loans), and $43.68 million at December 31, 2019 (0.99% of total loans).  

The Company plans to adopt CECL effective January 1, 2021 and does not expect its Day One CECL adjustment to be material. 

Capital 

The Company’s capital position during the December 2020 quarter was benefitted by net income of $3.03 million.

The Company’s and Bank’s capital ratios at December 31, 2020 all remain strong.  Such ratios remain well above regulatory well capitalized standards.

As previously noted, and as previously announced, in the fourth quarter of 2020 the Company successfully completed a private placement of $100 million in fixed-to floating rate subordinated notes due 2030 at a rate of 3.5%. Such funds benefitted the Company’s Regulatory Tier 2 Capital. The proceeds raised will be used for general corporate purposes, which will include stock repurchases and could potentially include redemption of the Company’s existing 6% subordinated debt and acquisitions of wealth management firms. 

The Company employs quarterly capital stress testing run under multiple scenarios, including a no growth, severely adverse case. In such case as of September 30, 2020, the Bank remains well capitalized over a two-year stress period. With a Pandemic stress overlay on this case, the Bank still remains well capitalized over the two-year stress period. For further details, see the Q4 2020 Investor Update (and Supplemental Financial Information). 

As previously announced on January 28, 2021, the Company declared a cash dividend of $0.05 per share payable on February 26, 2021 to shareholders of record on February 11, 2021.

ABOUT THE COMPANY

Peapack-Gladstone Financial Corporation is a New Jersey bank holding company with total assets of $5.9 billion and AUM/AUA administration of $8.8 billion as of December 31, 2020.  Founded in 1921, Peapack-Gladstone Bank is a commercial bank that provides innovative wealth management, commercial and retail solutions, including residential lending and online platforms, to businesses and consumers.  Peapack Private, the bank’s wealth management division, offers comprehensive financial, tax, fiduciary and investment advice and solutions, to individuals, families, privately-held businesses, family offices and not-for-profit organizations, which help them to establish, maintain and expand their legacy.  Together, Peapack-Gladstone Bank and Peapack Private offer an unparalleled commitment to client service.  Visit www.pgbank.com and www.peapackprivate.com for more information.

The foregoing may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements are not historical facts and include expressions about management’s confidence and strategies and management’s expectations about new and existing programs and products, investments, relationships, opportunities and market conditions.  These statements may be identified by such forward-looking terminology as “expect,” “look,” “believe,” “anticipate,” “may” or similar statements or variations of such terms.  Actual results may differ materially from such forward-looking statements.  Factors that may cause results to differ materially from such forward-looking statements include, but are not limited to:

• our inability to successfully grow our business and implement our strategic plan, including an inability to generate revenues to offset the increased personnel and other costs related to the strategic plan;
• the impact of anticipated higher operating expenses in 2021 and beyond;
• our inability to successfully integrate wealth management firm acquisitions;
• our inability to manage our growth;
• our inability to successfully integrate our expanded employee base;
• an unexpected decline in the economy, in particular in our New Jersey and New York market areas;
• declines in our net interest margin caused by the interest rate environment and/or our highly competitive market;
• declines in value in our investment portfolio;
• impact on our business from a pandemic event on our business, operations, customers, allowance for loan losses and capital levels;
• higher than expected increases in our allowance for loan and lease losses;
• higher than expected increases in loan and lease losses or in the level of nonperforming loans;
• changes in interest rates;
• decline in real estate values within our market areas;
• legislative and regulatory actions (including the impact of the Dodd-Frank Wall Street Reform and Consumer Protection Act, Basel III and related regulations) that may result in increased compliance costs;
• successful cyberattacks against our IT infrastructure and that of our IT and third-party providers;
• higher than expected FDIC insurance premiums;
• adverse weather conditions;
• our inability to successfully generate new business in new geographic markets;
• our inability to execute upon new business initiatives;
• our lack of liquidity to fund our various cash obligations;
• reduction in our lower-cost funding sources;
• our inability to adapt to technological changes; 
• claims and litigation pertaining to fiduciary responsibility, environmental laws and other matters;
• our inability to retain key employees;
• demands for loans and deposits in our market areas;
• adverse changes in securities markets;
• changes in accounting policies and practices; and
• other unexpected material adverse changes in our operations or earnings.

Further, given its ongoing and dynamic nature, it is difficult to predict the full impact of the COVID-19 outbreak on our business. The extent of such impact will depend on future developments, which are highly uncertain, including when the coronavirus can be controlled and abated and when and whether the gradual reopening of businesses will result in a meaningful increase in economic activity.  As the result of the COVID-19 pandemic and the related adverse local and national economic consequences, we could be subject to any of the following risks, any of which could have a material, adverse effect on our business, financial condition, liquidity, and results of operations: 

• demand for our products and services may decline, making it difficult to grow assets and income; 
• if the economy is unable to substantially reopen, and high levels of unemployment continue for an extended period of time, loan delinquencies, problem assets, and foreclosures may increase, resulting in increased charges and reduced income; 
• collateral for loans, especially real estate, may decline in value, which could cause loan losses to increase; 
• our allowance for loan losses may have to be increased if borrowers experience financial difficulties, which will adversely affect our net income; 
• the net worth and liquidity of loan guarantors may decline, impairing their ability to honor commitments to us; 
• as the result of the decline in the Federal Reserve Board’s target federal funds rate to near 0%, the yield on our assets may decline to a greater extent than the decline in our cost of interest-bearing liabilities, reducing our net interest margin and spread and reducing net income; 
• a material decrease in net income or a net loss over several quarters could result in a decrease in the rate of our quarterly cash dividend; 
• our wealth management revenues may decline with continuing market turmoil; 
• a worsening of business and economic conditions or in the financial markets could result in an impairment of certain intangible assets, such as goodwill;
• the unanticipated loss or unavailability of key employees due to the outbreak, which could harm our ability to operate our business or execute our business strategy, especially as we may not be successful in finding and integrating suitable successors;
• we may face litigation, regulatory enforcement and reputation risk as a result of our participation in the PPP and the risk that the SBA may not fund some or all PPP loan guaranties;
• our cyber security risks are increased as the result of an increase in the number of employees working remotely; and 
• FDIC premiums may increase if the agency experience additional resolution costs.

A discussion of these and other factors that could affect our results is included in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2019.  We undertake no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company’s expectations.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

 (Tables to follow)

PEAPACK-GLADSTONE FINANCIAL CORPORATION

SELECTED CONSOLIDATED FINANCIAL DATA

(Dollars in Thousands, except share data)

(Unaudited)

		For the Three Months Ended
		Dec 31,				Sept 30,				June 30,				March 31,				Dec 31,
		2020				2020				2020				2020				2019
Income Statement Data:
Interest income		$	38,532			$	40,174			$	41,649			$	45,395			$	45,556
Interest expense			6,797				8,025				9,678				13,648				14,642
Net interest income			31,735				32,149				31,971				31,747				30,914
Wealth management fee income			10,791				10,119				9,996				9,955				10,120
Service charges and fees			859				785				695				816				893
Bank owned life insurance			313				314				318				328				325
Gain on loans held for sale at fair value    (Mortgage banking) (A)			1,470				954				550				292				344
Gain/(loss) on loans held for sale at lower of cost or    fair value (B)			—				7,429				—				(3	)			(4	)
Fee income related to loan level, back-to-back    swaps (A)			—				—				202				1,418				2,459
Gain on sale of SBA loans (A)			375				79				258				1,054				929
Other income			640				531				482				459				504
Securities gains/(losses), net			(42	)			—				125				198				(45	)
Total other income			14,406				20,211				12,626				14,517				15,525
Salaries and employee benefits			19,902				19,202				19,186				19,226				17,954
Premises and equipment			4,189				4,109				4,036				4,043				3,898
FDIC insurance expense			665				605				455				250				—
FHLB prepayment penalty			4,784				—				—				—				—
Valuation allowance loans held for sale (C)			4,425				—				—				—				—
Other expenses			5,284				4,545				5,337				4,716				4,849
Total operating expenses			39,249				28,461				29,014				28,235				26,701
Pretax income before provision for loan losses			6,892				23,899				15,583				18,029				19,738
Provision for loan and lease losses (D)			2,350				5,150				4,900				20,000				1,950
Income/(loss) before income taxes			4,542				18,749				10,683				(1,971	)			17,788
Income tax expense/(benefit) (E)			1,512				5,202				2,441				(3,344	)			5,555
Net income		$	3,030			$	13,547			$	8,242			$	1,373			$	12,233
Total revenue (F)		$	46,141			$	52,360			$	44,597			$	46,264			$	46,439
Per Common Share Data:
Earnings per share (basic)		$	0.16			$	0.72			$	0.44			$	0.07			$	0.64
Earnings per share (diluted)			0.16				0.71				0.43				0.07				0.64
Weighted average number of common    shares outstanding:
Basic			18,947,864				18,908,337				18,872,070				18,858,343				18,966,917
Diluted			19,334,569				19,132,650				19,059,822				19,079,575				19,207,738
Performance Ratios:
Return on average assets annualized (ROAA)			0.21	%			0.89	%			0.56	%			0.11	%			0.98	%
Return on average equity annualized (ROAE)			2.32	%			10.53	%			6.56	%			1.08	%			9.81	%
Net interest margin (tax-equivalent basis)			2.25	%			2.20	%			2.27	%			2.57	%			2.60	%
GAAP efficiency ratio (F)			85.06	%			54.36	%			65.06	%			61.03	%			57.50	%
Operating expenses / average assets annualized			2.66	%			1.86	%			1.97	%			2.18	%			2.13	%

1. Gain on loans held for sale at fair value (mortgage banking), fee income related to loan level, back-to-back swaps and gain on sale of SBA loans are all included in “capital markets activity” as referred to within the earnings release.
2. Includes gain on sale of PPP loans of $355 million completed in the September quarter.
3. The December 2020 quarter reflects a $4.4 million write-down of a commercial real estate loan associated with an assisted living facility.
4. The March 2020, June 2020 and September 2020 quarters included a higher provision for loan and lease losses primarily due to the environment created by the COVID-19 pandemic.
5. The March 2020 quarter included a $3.2 million tax benefit related to the carryback of tax NOLs to prior years when the Federal tax rate was 14% higher.
6. Total revenue includes net interest income plus total other income.
7. Calculated as total operating expenses as a percentage of total revenue.  For Non-GAAP efficiency ratio, see Non-GAAP financial measures reconciliation included in these tables.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

SELECTED CONSOLIDATED FINANCIAL DATA

(Dollars in Thousands, except share data)

(Unaudited)

		For the Twelve Months Ended
		December 31,								Change
		2020				2019				$				%
Income Statement Data:
Interest income		$	165,750			$	180,670			$	(14,920	)			-8	%
Interest expense			38,148				60,396				(22,248	)			-37	%
Net interest income			127,602				120,274				7,328				6	%
Wealth management fee income			40,861				38,363				2,498				7	%
Service charges and fees			3,155				3,488				(333	)			-10	%
Bank owned life insurance			1,273				1,321				(48	)			-4	%
Gain on loans held for sale at fair value (Mortgage banking) (A)			3,266				721				2,545				353	%
Gain/(loss) on loans held for sale at lower of cost or    fair value (B)			7,426				(10	)			7,436				-74360	%
Fee income related to loan level, back-to-back swaps (A)			1,620				5,799				(4,179	)			-72	%
Gain on sale of SBA loans (A)			1,766				2,145				(379	)			-18	%
Other income			2,112				2,752				(640	)			-23	%
Securities gains/(losses), net			281				117				164				140	%
Total other income			61,760				54,696				7,064				13	%
Salaries and employee benefits			77,516				70,129				7,387				11	%
Premises and equipment			16,377				14,735				1,642				11	%
FDIC insurance expense			1,975				277				1,698				613	%
FHLB prepayment penalty			4,784				—				4,784			N/A
Valuation allowance loans held for sale (C)			4,425				—				4,425			N/A
Other expenses			19,882				19,707				175				1	%
Total operating expenses			124,959				104,848				20,111				19	%
Pretax income before provision for loan losses			64,403				70,122				(5,719	)			-8	%
Provision for loan and lease losses (D)			32,400				4,000				28,400				710	%
Income before income taxes			32,003				66,122				(34,119	)			-52	%
Income tax (benefit)/expense (E)			5,811				18,688				(12,877	)			-69	%
Net income		$	26,192			$	47,434			$	(21,242	)			-45	%
Total revenue (F)		$	189,362			$	174,970			$	14,392				8	%
Per Common Share Data:
Earnings per share (basic)		$	1.39			$	2.46			$	(1.07	)			-43	%
Earnings per share (diluted)			1.37				2.44				(1.07	)			-44	%
Weighted average number of common shares outstanding:
Basic			18,896,825				19,268,870				(372,045	)			-2	%
Diluted			19,081,187				19,411,448				(330,261	)			-2	%
Performance Ratios:
Return on average assets annualized (ROAA)			0.45	%			0.99	%			(0.54	)%			-54	%
Return on average equity annualized (ROAE)			5.11	%			9.70	%			(4.59	)%			-47	%
Net interest margin (tax-equivalent basis)			2.31	%			2.63	%			(0.32	)%			-12	%
GAAP efficiency ratio (F)			65.99	%			59.92	%			6.07	%			10	%
Operating expenses / average assets annualized			2.16	%			2.19	%			(0.03	)%			-1	%

1. Gain on loans held for sale at fair value (mortgage banking), fee income related to loan level, back-to-back swaps and gain on sale of SBA loans are all included in “capital markets activity” as referred to within the earnings release.
2. Includes gain on sale of PPP loans of $355 million completed in the September 2020 quarter.
3. The 2020 year reflects a $4.4 million write down of a commercial real estate loan associated with an assisted living facility.
4. The increase in the provision for loan and lease losses in 2020 was primarily due to the environment created by the COVID-19 pandemic. 
5. 2020 year included a $3.2 million tax benefit related to the carryback of tax NOLs to prior years when the Federal tax rate was 14% higher.
6. Total revenue includes net interest income plus total other income.
7. Calculated as total operating expenses as a percentage of total revenue.  For Non-GAAP efficiency ratio, see Non-GAAP financial measures reconciliation included in these tables.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

CONSOLIDATED STATEMENTS OF CONDITION

(Dollars in Thousands)

(Unaudited)

		As of
		Dec 31,				Sept 30,				June 30,				March 31,				Dec 31,
		2020				2020				2020				2020				2019
ASSETS
Cash and due from banks		$	10,629			$	8,400			$	5,608			$	6,171			$	6,591
Federal funds sold			102				102				102				102				102
Interest-earning deposits			642,591				670,863				617,117				767,730				201,492
Total cash and cash equivalents			653,322				679,365				622,827				774,003				208,185
Securities available for sale			622,689				596,929				539,742				400,558				390,755
Equity security			15,117				15,159				15,159				14,034				10,836
FHLB and FRB stock, at cost			13,709				18,433				18,598				40,871				24,068
Residential mortgage			520,188				532,120				536,015				532,063				552,019
Multifamily mortgage			1,127,198				1,168,796				1,178,494				1,203,487				1,210,003
Commercial mortgage			694,034				722,678				761,910				760,648				761,244
Commercial loans (A)			1,975,337				1,930,984				2,316,125				1,810,214				1,776,450
Consumer loans			37,016				51,859				53,111				53,365				54,372
Home equity lines of credit			50,547				52,194				54,006				55,856				57,248
Other loans			225				260				272				347				349
Total loans			4,404,545				4,458,891				4,899,933				4,415,980				4,411,685
Less: Allowances for loan and lease losses			67,309				66,145				66,065				63,783				43,676
Net loans			4,337,236				4,392,746				4,833,868				4,352,197				4,368,009
Premises and equipment			21,609				21,668				21,449				21,243				20,913
Other real estate owned			50				50				50				50				50
Accrued interest receivable			22,495				22,192				15,956				11,816				10,494
Bank owned life insurance			46,809				46,645				46,479				46,309				46,128
Goodwill and other intangible assets			43,891				39,622				39,943				40,265				40,588
Finance lease right-of-use assets			4,330				4,517				4,704				4,891				5,078
Operating lease right-of-use assets			9,421				10,011				10,810				11,553				12,132
Other assets (B)			99,764				110,770				111,630				113,668				45,643
TOTAL ASSETS		$	5,890,442			$	5,958,107			$	6,281,215			$	5,831,458			$	5,182,879
LIABILITIES
Deposits:
Noninterest-bearing demand deposits		$	833,500			$	838,307			$	911,989			$	581,085			$	529,281
Interest-bearing demand deposits			1,849,254				1,858,529				1,804,102				1,680,452				1,510,363
Savings			130,731				127,737				123,140				112,668				112,652
Money market accounts			1,298,885				1,251,349				1,183,603				1,163,410				1,196,313
Certificates of deposit – Retail			530,222				586,801				629,941				651,000				633,763
Certificates of deposit – Listing Service			32,128				32,677				35,327				38,895				47,430
Subtotal “customer” deposits			4,674,720				4,695,400				4,688,102				4,227,510				4,029,802
IB Demand – Brokered			110,000				130,000				130,000				180,000				180,000
Certificates of deposit – Brokered			33,764				33,750				33,736				33,723				33,709
Total deposits			4,818,484				4,859,150				4,851,838				4,441,233				4,243,511
Short-term borrowings			15,000				15,000				15,000				515,000				128,100
FHLB advances (C)			—				105,000				105,000				105,000				105,000
Paycheck Protection Program Liquidity Facility (D)			177,086				183,790				535,837				—				—
Finance lease liability			6,753				6,976				7,196				7,402				7,598
Operating lease liability			9,737				10,318				11,116				11,852				12,423
Subordinated debt, net (E)			181,794				83,585				83,529				83,473				83,417
Other liabilities (B)			154,466				156,472				163,719				160,173				91,227
Due to brokers			—				15,088				—				10,885				7,951
TOTAL LIABILITIES			5,363,320				5,435,379				5,773,235				5,335,018				4,679,227
Shareholders’ equity			527,122				522,728				507,980				496,440				503,652
TOTAL LIABILITIES AND
SHAREHOLDERS’ EQUITY		$	5,890,442			$	5,958,107			$	6,281,215			$	5,831,458			$	5,182,879
Assets under management and / or administration at    Peapack-Gladstone Bank’s Private Wealth Management    Division (market value, not included above-dollars in billions)		$	8.8			$	7.6			$	7.2			$	6.4			$	7.5

1. Includes PPP loans of $196 million at December 31, 2020, $202 million at September 30, 2020 and $547 million at June 30, 2020.
2. The increase in other assets and other liabilities at March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020 was primarily due to the change in the fair value of our back-to-back swap program.
3. The Company prepaid $105 million of FHLB Advances with a weighted-average rate of 3.20% during the December 2020 quarter.
4. Represents funding provided by the Federal Reserve for pledged PPP loans.
5. The increase was due to the completion of a $100 million subordinated debt offering in December 22, 2020.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

SELECTED BALANCE SHEET DATA

(Dollars in Thousands)

(Unaudited)

		As of
		Dec 31,				Sept 30,				June 30,				March 31,				Dec 31,
		2020				2020				2020				2020				2019
Asset Quality:
Loans past due over 90 days and still accruing		$	—			$	—			$	—			$	—			$	—
Nonaccrual loans (A)			11,410				8,611				26,697				29,324				28,881
Other real estate owned			50				50				50				50				50
Total nonperforming assets		$	11,460			$	8,661			$	26,747			$	29,374			$	28,931
Nonperforming loans to total loans			0.26	%			0.19	%			0.54	%			0.66	%			0.65	%
Nonperforming assets to total assets			0.19	%			0.15	%			0.43	%			0.50	%			0.56	%
Performing TDRs (B)(C)		$	201			$	2,278			$	2,376			$	2,389			$	2,357
Loans past due 30 through 89 days and still accruing (D)(E)		$	5,053			$	6,609			$	3,785			$	8,261			$	1,910
Loans subject to special mention		$	162,103			$	129,700			$	27,922			$	13,222			$	13,643
Classified loans		$	37,771			$	41,263			$	63,562			$	58,938			$	58,908
Impaired loans		$	16,204			$	15,514			$	33,708			$	36,369			$	35,924
Allowance for loan and lease losses:
Beginning of period		$	66,145			$	66,065			$	63,783			$	43,676			$	41,580
Provision for loan and lease losses			2,350				5,150				4,900				20,000				1,950
(Charge-offs)/recoveries, net			(1,186	)			(5,070	)			(2,618	)			107				146
End of period		$	67,309			$	66,145			$	66,065			$	63,783			$	43,676
ALLL to nonperforming loans			589.91	%			768.15	%			247.46	%			217.51	%			151.23	%
ALLL to total loans (F)			1.53	%			1.48	%			1.35	%			1.44	%			0.99	%
General ALLL to total loans (G)			1.47	%			1.48	%			1.26	%			1.30	%			0.93	%

1. Excludes residential and commercial loans held for sale of $8.5 million at December 31, 2020.  Excludes one commercial loan held for sale of $10.0 million at September 30, 2020.
2. Amounts reflect TDRs that are paying according to restructured terms.
3. Amount does not include $4.0 million at December 31, 2020, $5.2 million at September 30, 2020, $23.2 million at June 30, 2020, $25.9 million at March 31, 2020 and $25.8 million at December 31, 2019 of TDRs included in nonaccrual loans.
4. Excludes a residential loan held for sale of $93,000 at December 31, 2020.
5. December 31, 2020 includes $1.3 million of residential loans that are classified as delinquent due to an escrow payment shortage due to a recent change in escrow payment requirement.
6. If PPP loans of $196 million were excluded from loans at December 31, 2020, the ALLL/loans ratio would be 1.61%; if PPP loans of $202 million were excluded from loans at September 30, 2020, ALLL/ loans ratio would be 1.56%; and if PPP loans of $547 million were excluded from loans at June 30, 2020, ALLL/loans ratio would be 1.52%.
7. Total ALLL less specific reserves equals general ALLL.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

SELECTED BALANCE SHEET DATA

(Dollars in Thousands)

(Unaudited)

		December 31,						September 30,						December 31,
		2020						2020						2019
Capital Adequacy
Equity to total assets (A)(J)					8.95	%					8.77	%					9.72	%
Tangible Equity to tangible assets (B)					8.27	%					8.16	%					9.01	%
Tangible Equity to tangible assets excluding    PPP loans (C)					8.55	%					8.45	%					9.01	%
Book value per share (D)				$	27.78					$	27.62					$	26.61
Tangible Book Value per share (E)				$	25.47					$	25.53					$	24.47

		December 31,								September 30,								December 31,
		2020								2020								2019
Regulatory Capital – Holding Company
Tier I leverage		$	483,535			8.53%				$	483,782			8.54%				$	463,521			9.33%
Tier I capital to risk-weighted assets			483,535				11.93				483,782				11.76				463,521				11.14
Common equity tier I capital ratio    to risk-weighted assets			483,500				11.93				483,747				11.75				463,520				11.14
Tier I & II capital to risk-weighted assets			716,210				17.67				618,993				15.04				590,614				14.20
Regulatory Capital – Bank
Tier I leverage (F)		$	549,575			9.71%				$	547,761			9.68%				$	527,833			10.63%
Tier I capital to risk-weighted assets (G)			549,575				13.55				547,761				13.33				527,833				12.70
Common equity tier I capital ratio    to risk-weighted assets (H)			549,540				13.55				547,726				13.33				527,832				12.70
Tier I & II capital to risk-weighted assets (I)			600,478				14.81				599,314				14.58				571,509				13.76

1. Equity to total assets is calculated as total shareholders’ equity as a percentage of total assets at period end.
2. Tangible equity and tangible assets are calculated by excluding the balance of intangible assets from shareholders’ equity and total assets, respectively. Tangible equity as a percentage of tangible assets at period end is calculated by dividing tangible equity by tangible assets at period end.  See Non-GAAP financial measures reconciliation included in these tables.
3. Tangible equity and tangible assets excluding PPP loans are calculated by excluding the balance of intangible assets from shareholders’ equity and excluding the balance of intangible assets and PPP loans from total assets. Tangible equity as a percentage of tangible assets excluding PPP loans at period end is calculated by dividing tangible equity by tangible assets excluding PPP loans at period end.  See Non-GAAP financial measures reconciliation included in these tables.
4. Book value per common share is calculated by dividing shareholders’ equity by period end common shares outstanding
5. Tangible book value per excludes intangible assets.  Tangible book value per share is calculated by dividing tangible equity by period end common shares outstanding.  See Non-GAAP financial measures reconciliation tables.
6. Regulatory well capitalized standard = 5.00% ($283 million)
7. Regulatory well capitalized standard = 8.00% ($324 million)
8. Regulatory well capitalized standard = 6.50% ($264 million)
9. Regulatory well capitalized standard = 10.00% ($406 million)
10. PPP loans with a balance of $196 million and $202 million increased total assets at December 31, 2020 and September 30, 2020, respectively.  Equity to total assets would be 9.26% and 9.08% if PPP loans were excluded from total assets at December 31, 2020 and September 30, 2020, respectively.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

LOANS CLOSED

(Dollars in Thousands)

(Unaudited)

		For the Quarters Ended
		Dec 31,				Sept 30,				June 30,				March 31,				Dec 31,
		2020				2020				2020				2020				2019
Residential loans retained		$	22,316			$	32,599			$	18,627			$	14,831			$	17,115
Residential loans sold			64,630				54,521				37,061				19,391				21,255
Total residential loans			86,946				87,120				55,688				34,222				38,370
Commercial real estate			—				1,613				748				8,858				52,630
Multifamily			1,184				1,500				11,960				61,998				63,627
Commercial (C&I) loans (A) (B)			218,235				118,048				99,294				42,908				174,946
SBA (C)			8,355				4,962				595,651				13,830				19,195
Wealth lines of credit (A)			3,925				2,000				500				3,250				42,575
Total commercial loans			231,699				128,123				708,153				130,844				352,973
Installment loans			690				253				950				256				984
Home equity lines of credit (A)			2,330				4,759				4,280				3,632				2,414
Total loans closed		$	321,665			$	220,255			$	769,071			$	168,954			$	394,741

		For the Twelve Months Ended
		Dec 31,				Dec 31,
		2020				2019
Residential loans retained		$	88,373			$	69,025
Residential loans sold			175,603				49,976
Total residential loans			263,976				119,001
Commercial real estate			11,219				151,273
Multifamily			76,642				220,491
Commercial (C&I) loans (A) (B)			478,485				688,921
SBA (C)			622,798				35,495
Wealth lines of credit (A)			9,675				63,660
Total commercial loans			1,198,819				1,159,840
Installment loans			2,149				3,401
Home equity lines of credit (A)			15,001				13,278
Total loans closed		$	1,479,945			$	1,295,520

1. Includes loans and lines of credit that closed in the period but not necessarily funded.
2. Includes equipment finance.
3. Includes PPP loans of $596 million for the three months ended June 30, 2020 and for the twelve months ended December 31, 2020.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

AVERAGE BALANCE SHEET

UNAUDITED
THREE MONTHS ENDED
(Tax-Equivalent Basis, Dollars in Thousands)

		December 31, 2020												December 31, 2019
		Average				Income/								Average				Income/
		Balance				Expense				Yield				Balance				Expense				Yield
ASSETS:
Interest-earning assets:
Investments:
Taxable (A)		$	636,417			$	2,033				1.28	%		$	393,549			$	2,428				2.47	%
Tax-exempt (A) (B)			8,137				101				4.96				12,037				147				4.88
Loans (B) (C):
Mortgages			520,123				4,372				3.36				557,132				4,780				3.43
Commercial mortgages			1,865,953				14,796				3.17				1,959,902				18,588				3.79
Commercial			1,943,855				16,587				3.41				1,662,026				18,413				4.43
Commercial construction			10,376				108				4.16				4,842.00				81.00				6.69
Installment			44,581				320				2.87				54,562				524				3.84
Home equity			51,545				429				3.33				58,082				662				4.56
Other			281				6				8.54				379				10				10.55
Total loans			4,436,714				36,618				3.30				4,296,925				43,058				4.01
Federal funds sold			102				—				0.25				102				—				0.25
Interest-earning deposits			614,024				148				0.10				159,759				560				1.40
Total interest-earning assets			5,695,394				38,900				2.73	%			4,862,372				46,193				3.80	%
Noninterest-earning assets:
Cash and due from banks			9,632												5,600
Allowance for loan and lease losses			(68,862	)											(42,374	)
Premises and equipment			21,698												20,946
Other assets			238,856												166,868
Total noninterest-earning assets			201,324												151,040
Total assets		$	5,896,718											$	5,013,412
LIABILITIES:
Interest-bearing deposits:
Checking		$	1,850,917			$	1,059				0.23	%		$	1,407,151			$	3,489				0.99	%
Money markets			1,273,681				811				0.25				1,169,413				3,456				1.18
Savings			128,195				17				0.05				112,597				16				0.06
Certificates of deposit – retail			602,068				2,106				1.40				660,159				3,734				2.26
Subtotal interest-bearing deposits			3,854,861				3,993				0.41				3,349,320				10,695				1.28
Interest-bearing demand – brokered			113,696				514				1.81				180,000				981				2.18
Certificates of deposit – brokered			33,756				267				3.16				33,702				267				3.17
Total interest-bearing deposits			4,002,313				4,774				0.48				3,563,022				11,943				1.34
Borrowings			244,753				616				1.01				221,462				1,383				2.50
Capital lease obligation			6,832				82				4.80				7,669				92				4.80
Subordinated debt			94,437				1,325				5.61				83,385				1,224				5.87
Total interest-bearing liabilities			4,348,335				6,797				0.63	%			3,875,538				14,642				1.51	%
Noninterest-bearing liabilities:
Demand deposits			858,004												539,501
Accrued expenses and other liabilities			166,933												99,702
Total noninterest-bearing liabilities			1,024,937												639,203
Shareholders’ equity			523,446												498,671
Total liabilities and shareholders’ equity		$	5,896,718											$	5,013,412
Net interest income						$	32,103											$	31,551
Net interest spread											2.10	%											2.29	%
Net interest margin (D)											2.25	%											2.60	%

1. Average balances for available for sale securities are based on amortized cost.
2. Interest income is presented on a tax-equivalent basis using a 21% federal tax rate.
3. Loans are stated net of unearned income and include nonaccrual loans.
4. Net interest income on a tax-equivalent basis as a percentage of total average interest-earning assets.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

AVERAGE BALANCE SHEET

UNAUDITED
THREE MONTHS ENDED
(Tax-Equivalent Basis, Dollars in Thousands)

		December 31, 2020												September 30, 20020
		Average				Income/								Average				Income/
		Balance				Expense				Yield				Balance				Expense				Yield
ASSETS:
Interest-earning assets:
Investments:
Taxable (A)		$	636,417			$	2,033				1.28	%		$	553,607			$	2,182				1.58	%
Tax-exempt (A) (B)			8,137				101				4.96				9,127				116				5.08
Loans (B) (C):
Mortgages			520,123				4,372				3.36				529,500				4,437				3.35
Commercial mortgages			1,865,953				14,796				3.17				1,929,319				15,115				3.13
Commercial			1,943,855				16,587				3.41				2,134,399				17,653				3.31
Commercial construction			10,376				108				4.16				4,395				55				5.01
Installment			44,581				320				2.87				52,659				377				2.86
Home equity			51,545				429				3.33				53,373				444				3.33
Other			281				6				8.54				283				7				9.89
Total loans			4,436,714				36,618				3.30				4,703,928				38,088				3.24
Federal funds sold			102				—				0.25				102				—				0.25
Interest-earning deposits			614,024				148				0.10				652,832				159				0.10
Total interest-earning assets			5,695,394				38,900				2.73	%			5,919,596				40,545				2.74	%
Noninterest-earning assets:
Cash and due from banks			9,632												7,479
Allowance for loan and lease losses			(68,862	)											(68,110	)
Premises and equipment			21,698												21,511
Other assets			238,856												242,017
Total noninterest-earning assets			201,324												202,897
Total assets		$	5,896,718											$	6,122,493
LIABILITIES:
Interest-bearing deposits:
Checking		$	1,850,917			$	1,059				0.23	%		$	1,828,780			$	1,130				0.25	%
Money markets			1,273,681				811				0.25				1,235,040				920				0.30
Savings			128,195				17				0.05				125,016				16				0.05
Certificates of deposit – retail			602,068				2,106				1.40				642,732				2,529				1.57
Subtotal interest-bearing deposits			3,854,861				3,993				0.41				3,831,568				4,595				0.48
Interest-bearing demand – brokered			113,696				514				1.81				130,000				636				1.96
Certificates of deposit – brokered			33,756				267				3.16				33,742				267				3.17
Total interest-bearing deposits			4,002,313				4,774				0.48				3,995,310				5,498				0.55
Borrowings			244,753				616				1.01				475,465				1,221				1.03
Capital lease obligation			6,832				82				4.80				7,054				84				4.76
Subordinated debt			94,437				1,325				5.61				83,552				1,222				5.85
Total interest-bearing liabilities			4,348,335				6,797				0.63	%			4,561,381				8,025				0.70	%
Noninterest-bearing liabilities:
Demand deposits			858,004												872,560
Accrued expenses and other liabilities			166,933												173,816
Total noninterest-bearing liabilities			1,024,937												1,046,376
Shareholders’ equity			523,446												514,736
Total liabilities and shareholders’ equity		$	5,896,718											$	6,122,493
Net interest income						$	32,103											$	32,520
Net interest spread											2.10	%											2.04	%
Net interest margin (D)											2.25	%											2.20	%

1. Average balances for available for sale securities are based on amortized cost.
2. Interest income is presented on a tax-equivalent basis using a 21% federal tax rate. 
3. Loans are stated net of unearned income and include nonaccrual loans.
4. Net interest income on a tax-equivalent basis as a percentage of total average interest-earning assets.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

AVERAGE BALANCE SHEET

UNAUDITED
TWELVE MONTHS ENDED
(Tax-Equivalent Basis, Dollars in Thousands)

		December 31, 2020												December 31, 2019
		Average				Income/								Average				Income/
		Balance				Expense				Yield				Balance				Expense				Yield
ASSETS:
Interest-earning assets:
Investments:
Taxable (A)		$	510,245			$	8,782				1.72	%		$	391,666			$	10,228				2.61	%
Tax-exempt (A) (B)			9,479				477				5.03				14,930				728				4.88
Loans (B) (C):
Mortgages			528,687				17,882				3.38				565,935				19,321				3.41
Commercial mortgages			1,958,262				64,541				3.30				1,857,014				72,061				3.88
Commercial			1,969,115				71,037				3.61				1,498,077				71,071				4.74
Commercial construction			5,932				295				4.97				1,881				132				7
Installment			51,007				1,532				3.00				54,555				2,246				4.12
Home equity			53,853				1,940				3.60				60,036				2,981				4.97
Other			311				29				9.32				391				42				10.74
Total loans			4,567,167				157,256				3.44				4,037,889				167,854				4.16
Federal funds sold			102				—				0.25				102				—				0.25
Interest-earning deposits			504,753				968				0.19				223,629				4,457				1.99
Total interest-earning assets			5,591,746				167,483				3.00	%			4,668,216				183,267				3.93	%
Noninterest-earning assets:
Cash and due from banks			7,025												5,477
Allowance for loan and lease losses			(61,401	)											(40,328	)
Premises and equipment			21,455												21,176
Other assets			219,287												142,156
Total noninterest-earning assets			186,366												128,481
Total assets		$	5,778,112											$	4,796,697
LIABILITIES:
Interest-bearing deposits:
Checking		$	1,742,846			$	7,279				0.42	%		$	1,342,901			$	15,789				1.18	%
Money markets			1,227,295				6,185				0.50				1,189,880				16,434				1.38
Savings			120,780				63				0.05				113,312				63				0.06
Certificates of deposit – retail			654,652				11,476				1.75				631,999				14,210				2.25
Subtotal interest-bearing deposits			3,745,573				25,003				0.67				3,278,092				46,496				1.42
Interest-bearing demand – brokered			143,388				2,773				1.93				180,000				3,457				1.92
Certificates of deposit – brokered			33,735				1,061				3.15				42,460				1,225				2.89
Total interest-bearing deposits			3,922,696				28,837				0.74				3,500,552				51,178				1.46
Borrowings			308,814				3,976				1.29				136,992				3,941				2.88
Capital lease obligation			7,157				343				4.79				7,956				382				4.80
Subordinated debt			86,246				4,992				5.79				83,300				4,895				5.88
Total interest-bearing liabilities			4,324,913				38,148				0.88	%			3,728,800				60,396				1.62	%
Noninterest-bearing liabilities:
Demand deposits			787,191												505,486
Accrued expenses and other liabilities			153,648												73,601
Total noninterest-bearing liabilities			940,839												579,087
Shareholders’ equity			512,360												488,810
Total liabilities and shareholders’ equity		$	5,778,112											$	4,796,697
Net interest income						$	129,335											$	122,871
Net interest spread											2.12	%											2.31	%
Net interest margin (D)											2.31	%											2.63	%

1. Average balances for available for sale securities are based on amortized cost.
2. Interest income is presented on a tax-equivalent basis using a 21% federal tax rate. 
3. Loans are stated net of unearned income and include nonaccrual loans.
4. Net interest income on a tax-equivalent basis as a percentage of total average interest-earning assets.

PEAPACK-GLADSTONE FINANCIAL CORPORATION

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Tangible book value per share and tangible equity as a percentage of tangible assets at period end are non-GAAP financial measures derived from GAAP-based amounts.  We calculate tangible equity and tangible assets by excluding the balance of intangible assets from shareholders’ equity and total assets, respectively.  We calculate tangible book value per share by dividing tangible equity by period end common shares outstanding, as compared to book value per common share, which we calculate by dividing shareholders’ equity by period end common shares outstanding.  We calculate tangible equity as a percentage of tangible assets at period end by dividing tangible equity by tangible assets at period end.  We believe that this is consistent with the treatment by bank regulatory agencies, which exclude intangible assets from the calculation of risk-based capital ratios.

The efficiency ratio is a non-GAAP measure of expense control relative to recurring revenue.  We calculate the efficiency ratio by dividing total noninterest expenses, excluding ORE provision, as determined under GAAP, by net interest income and total noninterest income as determined under GAAP, but excluding net gains/(losses) on loans held for sale at lower of cost or fair value and excluding net gains on securities from this calculation, which we refer to below as recurring revenue.  We believe that this provides one reasonable measure of core expenses relative to core revenue.

We believe that these non-GAAP financial measures provide information that is important to investors and that is useful in understanding our financial position, results and ratios.  Our management internally assesses our performance based, in part, on these measures.  However, these non-GAAP financial measures are supplemental and are not a substitute for an analysis based on GAAP measures.  As other companies may use different calculations for these measures, this presentation may not be comparable to other similarly titles measures reported by other companies.  A reconciliation of the non-GAAP measures of tangible common equity, tangible book value per share and efficiency ratio to the underlying GAAP numbers is set forth below.

Non-GAAP Financial Reconciliation

(Dollars in thousands, except share data)

		Three Months Ended
		Dec 31,				Sept 30,				June 30,				March 31,				Dec 31,
Tangible Book Value Per Share		2020				2020				2020				2020				2019
Shareholders’ equity		$	527,122			$	522,728			$	507,980			$	496,440			$	503,652
Less:  Intangible assets, net			43,891				39,622				39,943				40,265				40,588
Tangible equity			483,231				483,106				468,037				456,175				463,064
Period end shares outstanding			18,974,703				18,924,953				18,905,135				18,852,523				18,926,810
Tangible book value per share		$	25.47			$	25.53			$	24.76			$	24.20			$	24.47
Book value per share			27.78				27.62				26.87				26.33				26.61
Tangible Equity to Tangible Assets
Total assets		$	5,890,442			$	5,958,107			$	6,281,215			$	5,831,458			$	5,182,879
Less: Intangible assets, net			43,891				39,622				39,943				40,265				40,588
Tangible assets			5,846,551				5,918,485				6,241,272				5,791,193				5,142,291
Less: PPP Loans			195,574				201,991				547,004				—				—
Tangible Assets excluding PPP Loans			5,650,977				5,716,494				5,694,268				5,791,193				5,142,291
Tangible equity to tangible assets			8.27	%			8.16	%			7.50	%			7.88	%			9.01	%
Tangible equity to tangible assets excluding PPP loans			8.55	%			8.45	%			8.22	%			7.88	%			9.01	%
Equity to assets (A)			8.95	%			8.77	%			8.09	%			8.51	%			9.72	%

1. Equity to total assets would be 9.26% if PPP loans of $196 million were excluded from total assets as of December 31, 2020. Equity to total assets would be 9.08% if PPP loans of $202 million were excluded from total assets as of September 30, 2020. Equity to total assets would be 8.86% if PPP loans of $547 million were excluded from total assets as of June 30, 2020.

		Three Months Ended
		Dec 31,				Sept 30,				June 30,				March 31,				Dec 31,
Efficiency Ratio		2020				2020				2020				2020				2019
Net interest income		$	31,735			$	32,149			$	31,971			$	31,747			$	30,914
Total other income			14,406				20,211				12,626				14,517				15,525
Less:
(Gain)/loss on loans held for sale
at lower of cost or fair value			—				(7,429	)			—				3				4
Securities losses/(gains), net			42				—				(125	)			(198	)			45
Total recurring revenue			46,183				44,931				44,472				46,069				46,488
Operating expenses			39,249				28,461				29,014				28,235				26,701
Less:
FHLB prepayment penalty			4,784				—				—				—				—
Valuation allowance loans held for sale			4,425				—				—				—				—
Total operating expense			30,040				28,461				29,014				28,235				26,701
Efficiency ratio			65.05	%			63.34	%			65.24	%			61.29	%			57.44	%

		For the Twelve Months Ended
		Dec 31,				Dec 31,
Efficiency Ratio		2020				2019
Net interest income		$	127,602			$	120,274
Total other income			61,760				54,696
Less:
Securities (gains)/losses, net			(281	)			(117	)
(Gain)/loss on loans held for sale
at lower of cost or fair value			(7,426	)			10
Total recurring revenue			181,655				174,863
Operating expenses			124,959				104,848
Less:
FHLB prepayment penalty			4,784				—
Valuation allowance loans held for sale			4,425				—
Total operating expense			115,750				104,848
Efficiency ratio			63.72	%			59.96	%

Contact:

Jeffrey J. Carfora, SEVP and CFO
Peapack-Gladstone Financial Corporation
T: 908-719-4308